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ABSTRACT OF THE DISSERTATION
Cognitive Recovery in the Post Infectious CNS
by
Charise Garber
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2020
Professor Robyn Klein, Chair

Neuroinflammation plays a pivotal role in a variety of diseases of the CNS associated
with cognitive impairment, including Alzheimer’s Disease, Parkinson’s Disease with dementia,
Multiple Sclerosis, anti-NMDA receptor encephalitis, and West Nile Virus Neuroinvasive
disease (WNND). Despite strong evidence that infiltration of peripheral immune cells and
activation of resident microglia and astrocytes occurs in these various diseases, very little is
known about how this altered immune environment may influence normal cognitive function.
Given that communication between the nervous and immune system is essential for normal
cognitive function, the central motivation of my thesis work is to understand the mechanisms by
which immune activation, which is vital for pathogen control, may influence cognitive recovery
in the setting of viral infection of the CNS.
First, using a recovery model of WNND in which intracranial infection of adult mice
with an attenuated strain of West Nile Virus leads to spatial learning deficits on the Barnes Maze
viii

behavioral task, we demonstrate that following viral clearance activated astrocytes express the
cytokine interleukin-1 (IL-1) which decreases neurogenesis and increases the generation of
astrocytes. Animals deficient in the receptor for IL-1 (IL1R1-/-) are protected from this decrease
in neurogenesis and display early recovery of synaptic terminals and protection from virusinduced spatial learning deficits. In addition, treatment of mice with Anakinra, an FDA-approved
IL-1R antagonist, during acute disease similarly led to protection from spatial learning deficits.
Next, using the same recovery model of WNND, we demonstrate that T cells persist in
the hippocampus for weeks following viral clearance and continue to express the cytokine
interferon-gamma (IFNg) leading to persistent activation of microglia. Animals deficient in the
receptor for IFNg (IFNgR-/-) are protected from microglial activation and spatial learning
deficits, despite delayed viral clearance and increased persistence of viral RNA in the
hippocampus compared to wildtype controls. Conditional deletion of IFNgR from microglia
upon tamoxifen administration to Cx3CR1-CreER x IFNgR-fl/fl mice was sufficient to protect
animals from spatial learning deficits. These results were confirmed in animals infected with
Zika-virus (ZIKV), a related flavivirus with different neural tropism, suggesting a common
mechanism by which altered immune activation in the CNS leads to long term cognitive deficits.
These studies provide valuable insights into the neuroimmune processes that influence tissue
repair and cognitive recovery in the hippocampus following viral encephalitis, and identify IFNg
signaling in microglia as a critical signal underlying diverse recovery mechanisms.
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Chapter 1: Introduction to neuroimmunity
and cognitive function
1.1 Overview of neuroimmunology and CNS function
Neuroinflammation is a hallmark of many diseases associated with cognitive impairment
including Alzheimer’s disease, Parkinson’s disease with dementia, multiple sclerosis, antiNMDA receptor encephalitis and viral encephalitis. However, even under homeostatic, diseasefree conditions, communication between the nervous and immune systems is essential for proper
brain function. This includes a role for microglia, the resident immune cells of the CNS, which
actively extend and retract their processes to remodel their local environment by engulfment of
synapses1–3 or newborn neurons4–6, and for T cells, non-resident adaptive immune cells, which
continuously patrol the CNS and influence cognitive processing through the secretion of
cytokines7–10. Thus, the neuroprotective or pathological effect of inflammation may depend on
specific cytokine expression induced in regionally distinct ways.

1.2 Microglia
1.2.1 Neurodevelopment
The Microglia arise from erythromyeloid progenitors (EMP) of the fetal yolk sac during
primitive hematopoiesis and begin seeding the CNS around E9.5 in mice11,12. In addition to
microglia, other myeloid cells of the CNS including perivascular, meningeal, and choroid plexus
macrophages also derive from EMPs of the fetal yolk sac and seed the CNS between E9.5-12.513.
The kinetics of microglial seeding into the CNS, coincident with angiogenesis and neurogenesis,
1

and prior to astrocyte and oligodendrocyte genesis, provides a unique opportunity for microglia
to influence neurodevelopment14. Indeed, ingenuity pathway analysis (IPA) of microglial gene
expression identified many functions associated with nervous system development15.
Several signaling pathways have been described which are important for microglial
development and maintenance in the adult brain including transforming growth factor (TGF)beta, the transcription factor Pu.1, interferon regulatory factor (IRF)-8 and colony stimulating
factor 1 receptor (CSF1R)11,15–18. CSF1R signaling is required for proliferation of yolk sac
macrophages, as such CSF1R-/- mice do not have microglia although microglia are present in the
CNS of animals lacking the ligand CSF1, which suggested an alternate CSF1R ligand is
important for maintenance of microglia in the CNS. IL-34 can also signal through CSF1R, and is
expressed by neurons in the cortex and hippocampus, but not the cerebellum of adult mice.
Accordingly, animals deficient in IL-34 show decreased numbers of microglia in the cortex and
hippocampus, with no changes observed in the cerebellum17,18.
Pioneering in vivo imaging studies revealed that microglia in the adult brain are highly
dynamic, constantly extending and retracting processes to sample the surrounding environment,
contacting neuronal cell bodies, astrocytes, blood vessels and synapses1,19,20. Transcriptome
analysis revealed that microglia in the adult brain express many genes involved in sensing the
environment, and the majority of these recognize intrinsic CNS antigens while a much smaller
percentage recognized bacterial or other pathogen associated products21, suggesting that
surveillance of the local environment represents an important microglial function.

1.2.2 Homeostatic function
During development, microglia play a crucial role in refining circuits by pruning excess
synapses2,3, or promoting the formation of new ones22,23. In the lateral geniculate nucleus of the
2

thalamus, visual circuits are modified through activity dependent synaptic pruning via
complement3. A recent report has also suggested a role for astrocyte derived IL-33, an IL-1
family member, in signaling to microglia to promote synapse pruning in the thalamus and spinal
cord during postnatal synapse maturation24. During adulthood, microglia contribute to learningdependent spine formation23.
As the specialized tissue-resident macrophage in the CNS, microglia have multiple
functions during development and adulthood related to phagocytosis of debris. In addition to the
pruning of synapses mentioned above, microglia also remove apoptotic purkinje cell neurons in
the developing cerebellum4, apoptotic newborn cells in the neurogenic niche of the
hippocampus5, and non-apoptotic tbr2+ neural progenitors in the developing cerebral cortex6.

1.2.3 Role in disease
Under homeostatic conditions, microglia, and other myeloid cells of the CNS derived from
EMPs of the yolk sac are long lived and are not replaced by circulating monocytes, with the
exception of choroid plexus macrophages which have more frequent turnover13. However, during
blood brain barrier disruption in the setting of disease, peripheral monocytes can be recruited
into the CNS parenchyma and contribute to the pathogenesis or resolution of disease. There
continues to be a strong debate over the relative contributions of peripheral-derived macrophages
and resident microglia in CNS diseases; in particular the ability of the former to enter and engraft
in the CNS and the ability of the latter to proliferate and expand in response to disease.
Following facial nerve axotomy, in which microgliosis is observed in the absence of blood brain
barrier breakdown, microglia seem to proliferate locally in response to the injury25. Single-cell
tracking by in vivo imaging confirmed the long-lived nature of microglial cells in the cortex, and
suggested that in the setting of Alzheimer’s disease the increased density of microglia around
3

plaques is most likely due to proliferation of neighboring microglia whose daughter cells migrate
towards the plaque26. These studies suggest that microglia can proliferate in response to disease.

1.2.4 Role in disease
Microglia isolated from different regions of the brain express unique genetic signatures27.
Cortical and striatal microglia cluster distinctly from cerebellar microglia, with hippocampal
microglial demonstrating an intermediate expression profile. Some of the most regionally distinct
pathways include those involved in immune function and energy metabolism, which are
increased in hippocampal and cerebellar microglia. Interestingly, hippocampal microglia show
particular variability in aging, acquiring a profile that more closely resembles cortical microglia.
In contrast, cerebellar microglia show increased expression of immune-related genes, consistent
with the immune vigilant status of the hindbrain (see section 1.4.4)27. Baseline differences in the
transcriptional profile of microglia suggest that microglia from distinct brain regions may
respond differently to infection or injury, providing an exciting new area of research to be
explored.

1.3 Astrocytes
1.3.1 Neurodevelopment
In the developing CNS, neurogenesis precedes astrogenesis. Astrocytes develop from the neural
stem cells, although the precise transcriptional cues regulating this “gliogenic switch” remain
unknown. Activation of the Janus kinase-signal transducer and activator of transcription (JAKSTAT) signaling pathway promotes astrocyte differentiation28,29. Fate-mapping revealed that
astrocytes proliferate in the ventricular zone and early astrocyte-restricted precursors migrate to
specific regions of the CNS according to their initial site of origin in the ventricular zone30,31. In
vivo imaging studies demonstrated that differentiated astrocytes in the cortex then divide
4

postnatally to expand and functionally integrate with other CNS cell types32. Thus both
asymmetric division occurring in germinal centers in late embryogenesis and symmetric division
occurring in the final brain region where they will reside accounts for the 6-8 fold increase in
astrocyte numbers observed in the first thee postnatal weeks33t.

1.3.2 Homeostatic function
Astrocytes perform a diverse array of functions in the developing and adult CNS. Astrocyte endfeet surround cerebrovascular endothelial cells to form the blood brain barrier which regulates
entry of molecules and cells into the CNS parenchyma34. Astrocytes also send processes toward
synaptic connections between neurons to regulate synapse formation and neurotransmitter
recycling35. Neighboring astrocytes are coupled electrically by gap junctions and buffer
extracellular ions, in particular potassium, through expression of the potassium channel Kir4.136.
Recent studies have identified unique roles for astrocytes in more complex behaviors. Astrocytes
located in the chemoreceptor areas of the brainstem, respond rapidly to changes in pH and
release ATP which triggered breathing in mice37. Astrocytes from other brain regions were not
sensitive to changes in pH, suggesting that astrocytes may acquire regionally distinct functions as
they integrate into CNS circuits37. Indeed, an early study found that astrocytes from the
hippocampus promote neurogenesis when cultured with neural stem cells, but astrocytes from
the spinal cord do not38. More recent studies have shown that astrocytes in the ventral (motor)
and dorsal (sensory) regions of the spinal cord display unique genetic signatures, which influence
axon orientation and synapse formation during development39 and astrocytes in the trigeminal
nucleus induce bursting in rhythmogenic neurons by secretion of the calcium binding protein
S100b40. Collectively, these studies demonstrate that astrocytes perform a wide range of
functions, which may be unique to the region of the CNS where they are found.
5

1.3.3 Role in disease
Astrocytes have long been known to react to injury, however the extent to which this reaction is
neuroprotective or pathological has become a recent focus in the field of glial biology. In a
pioneering study, Zamanian et al purified astrocytes from the CNS following two different types
of injury: ischemic injury by middle cerebral artery occlusion (MCAO) and neuroinflammation
by a single i.p. injection of LPS41. Transcriptional profiling revealed a set of genes which showed
increased expression after both MCAO and LPS, as well as genetic signatures that were unique
to one injury or the other41. A follow up study further refined the expression profile to define a
set of genes coined “pan-reactive” (upregulated in both MCAO and LPS), “A1” (upregulated
after LPS) and “A2” (upregulated after MCAO)42. Although the nomenclature has sparked some
criticism, in part due to controversy surrounding the M1/M2 designation for reactive microglia43,
these studies made important advances by identifying patterns of gene expression associated with
neuroprotective or neurotoxic responses.
Astrocytes can serve neuroprotective roles after CNS injury. Recent work has provided
evidence to challenge the prevailing the dogma that glial scar formation after spinal cord injury
prevents axonal regrowth. In an elegant series of experiments, Anderson et al prevented or
removed glial scars and did not see spontaneous regrowth of axons. However, delivery of growth
factors via synthetic hydrogel depots in the lesion led to robust regrowth of axons, and this
regrowth was significantly blunted in the absence of glial scar formation44. Another study
identified a unique mechanism of astrocyte-derived mitochondria to neurons to promote survival
following stroke45. Astrocytes can also serve neurotoxic roles after CNS injury or prevent
recovery. LPS reactive astrocytes release a neurotoxic factor, the identity of which is currently
6

unknown, which kills alpha motor neurons in vitro42. In a mouse model of Alzheimer’s disease,
plaque associated astrocytes produced increased levels of the inhibitory neurotransmitter GABA
which impaired synaptic plasticity and learning and memory46. These studies suggest a
functional diversity in the reaction of astrocytes to various types of CNS damage which may
promote or prevent recovery.

1.3.4 Enhanced innate immune responses of hindbrain neurons and
astrocytes
*The following section is adapted from a box I wrote for our published review47
Astrocytes from different brain regions display distinct immune signatures at baseline and in
response to an inflammatory stimulus. Early in vitro experiments demonstrated that brain stem
astrocytes had elevated MHC-II and ICAM-I expression compared to various forebrain
structures48. Cerebellar and spinal cord astrocytes additionally released higher basal levels of
many chemokines/cytokines in vitro compared to cortical astrocytes including IL-1B, CCL2, IL6, and IL-9, and brain region had specific effects on chemokine/cytokine levels following
exposure to HIV proteins49.
Neurons also display regional heterogeneity of innate immune response at baseline and in
response to infection. In situ hybridization studies demonstrate that ISG-49 (IFIT-3) is highly
expressed in the Purkinje cell layer of the cerebellum, corpus callosum, and choroid plexus
following LCMV infection. In contrast, ISG-56 (IFIT-1) is most highly expressed in the
olfactory bulb and olfactory neurons. Striking differences in ISG expression occurs even in
neuronal subpopulations within a given region. For example, while ISG-49 was resent at high
levels in Purkinje cell, molecular, and granule neurons of the cerebellum, ISG-56 was primarily
restricted to granule neuron layer while ISG-54 (IFIT-2) was found in the Purkinje cell layer.
7

Granule cell neurons also expressed high levels of ISG-49 and ISG-56 following WNV
infection50. In fact, differences in expression of innate immune genes can be seen at baseline.
Microarray analysis comparing granule cell neurons of the cerebellum to cortical neurons of the
cerebral cortex revealed that IFN related genes including Ifit1, Irf7, Stat1 and OasI were higher
in cerebellar granule cell neurons. Granule cell neurons displayed increased resistance to viral
infection at baseline and in response to IFN-b treatment. Indeed, even the kinetics response to
IFN-b treatment was increased in cerebellar granule cell neurons peak expression levels of
several genes including Ifit1, Rsad2, and Oas reached peak expression levels at an earlier time
point compared to cortical neurons51.

1.4 T cells
1.4.1 Meningeal Immunity
A growing body of literature has demonstrated the important role of meningeal T cells in
influencing spatial learning in mice52. Early experiments demonstrated that SCID mice, which
lack functional B and T cells, have impaired performance on the Morris Water Maze53. This
impairment in spatial learning was not due to differences in motor function or baseline
psychomotor abnormalities, and could be reversed with CD3 T cell replenishment54. Mice
undergoing a spatial learning task demonstrated an increase in CD4+ T cells in the meninges
relative to naïve mice which did not undergo cognitive testing8, and further studies demonstrated
a critical role for CD4+ T cells in spatial learning7,9. Importantly, surgical resection of deep
cervical lymph nodes led to an increase of CD4+ T cells in the meninges and was correlated with
deficits in spatial learning relative to sham operated controls55, suggesting that spatial learning
depends in part on maintenance of particular T cell subsets in the meninges9,55,56. The discovery
of meningeal lymphatics, which demonstrated a structural route for recirculation of meningeal
8

lymphocytes and drainage of cerebral spinal fluid (CSF), provides an important advance in
understanding the interchange between peripheral immune compartments and the CNS10,57.

1.4.2 Response to RNA virus infection
T cells play a critical role in viral clearance from the CNS, although the response must be
carefully controlled to limit immunopathology in an organ with limited capacity for repair. T cell
recruitment to the CNS occurs primarily via chemokine signaling pathways. During WNV
infection, neuronal production of CXCL10 leads to the recruitment of CXCR3+ T cells to the
CNS to control viral infection and promote survival58. Reactivation of recruited T cells occurs
via interaction with CD11c+ dendritic cells in an IL1R1 dependent manner59, and release of T
cells from the perivascular space into the parenchyma is in part mediated via alterations in
polarity of CXCL12 expression at the endothelium60. Recent work in a model of neurotropic
coronavirus infection highlights the importance of CD8+ T cell reactivation in perivascular
spaces of the CNS for viral control and survival. In this work, expression of CCL19 and 21 by
stromal endothelial and fibroblast reticular like cells in the perivascular spaces of the CNS was
shown to be important for coordinating recruitment and reactivation of antiviral CD8+ T cells to
the CNS via CCR7 signaling61. The specific chemokine milieu in the infected CNS appears to
also influence T cell activity and antiviral response. During acute infection with LCMV,
cytotoxic T lymphocytes express chemokines which leads to peripheral myeloid cell recruitment,
severe immunopathology and death62. However, during chronic LCMV infection, therapeutic
administration of virus specific T cells can lead to non-cytopathic clearance of virus63.
T cells can persist in the CNS for months to years following neurotropic infection with
dengue64, VSV65, WNV66,67 and influenza68, however the functional implications of this
persistence are relatively unknown. Tissue resident memory T cells (TRM cells) are a recently
9

described class of long lived memory T cells which reside in non-lymphoid tissues at sites of
prior antigen exposure and coordinate a rapid recall response to re-challenge69,70. TRM cells are
classically defined by the expression of the integrin aE (CD103) and the early activation marker
CD69, however expression of these two markers is not uniform across all circulationindependent TRM cells in non-lymphoid tissues. CD69 is rapidly upregulated upon activation
through TCR signaling and exposure to type I interferons, and interferes with signaling through
the sphingosine 1 phosphate 1 receptor S1P1, preventing T cell egress from the tissue71,72. In the
CNS, generation of TRM cells appears to be antigen dependent65,73. However, persistent antigen
exposure was not required for TRM persistence in the CNS65,68. CD69+ brain TRM cells also
express high levels of the pro-survival molecule Bcl-274, which may explain their long term
survival despite lack of continuous antigen exposure.
Consistent with studies of TRM cells in other tissues, brain TRM cells are poised to provide
enhanced protection against returning pathogens. An early study identified CD69+ CD8+ T cells
persisting in the CNS to 320 days post infection (the latest time point analyzed) which retained
killing function when exposed to peptide or virus loaded cells ex vivo68. More recent studies have
demonstrated that brain TRM cells can provide enhanced protection and survival in mice upon rechallenge74,75. This protection could occur despite depletion of peripheral CD4 and CD8 cells,
and was dependent on interferon-gamma and perforin production by the brain TRM cells74. While
these studies demonstrate the existence of brain TRM cells, and the capacity to provide functional
pathogen control upon re-exposure, very little is known about how the presence and activity of
persistent T cells may influence activity of resident CNS cells including microglia, astrocytes,
and neurons in the absence of overt infection.
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1.5 Hippocampal function in learning and memory
1.5.1 Hippocampal circuitry
The hippocampus plays a critical role in the processing, storage and retrieval of different types of
memory, in particular spatial memory. Memory is encoded through a feedforward circuit loop
that centers around the CA3 region of the hippocampus76. The CA3 receives input from the
entorhinal cortex either directly through the perforant path, or indirectly through the dentate
gyrus (DG). There are excitatory connections between CA3 pyramidal cells, as well as inhibitory
input from CA3 interneurons. The primary output of the CA3 is through axons which synapse on
CA1 pyramidal cells and interneurons76. Different sub-regions of the hippocampus have distinct
functions in computational memory processing. In particular, the dentate gyrus, which receives
numerous connections from the entorhinal cortex but sends sparse input to the CA3, is
responsible for pattern separation77. The excitatory connections between CA3 pyramidal cells
allow for pattern completion to integrate new spatial memory information into the pattern of
what was previously experienced77. Elegant studies using a multi-electrode approach to
simultaneously record neurons in the DG and CA3 during a spatial processing task in which
local and global cues were spatially rotated at distinct angles provided experimental and
computational evidence for this long-standing, anatomically-based, hypothesis78.

1.5.2 Hippocampal circuitry
Neurogenesis occurs in two distinct brain regions in adult animals: the subgranular zone (SGZ)
of the dentate gyrus (DG), and the subventricular zone (SVZ) of the lateral ventricles79. Genetic
labeling studies demonstrated that SVZ neurogenesis contributes to the replacement of olfactory
bulb neurons without a change in overall number80. In contrast, neurogenesis in the SGZ appears
to account for the increase in the number of DG neurons observed as animals age80. Blockade of
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neurogenesis by radiation or anti-mitotic drugs has led to mixed results over the requirement of
adult neurogenesis for spatial learning in adult mice81. However, specific targeting of neural
precursor cells by genetic ablation in C57BL/6 mice demonstrated that adult neurogenesis is
important for spatial learning and memory recall on the Barnes Maze behavioral task80. More
specifically, hippocampal neurogenesis appears to be important for pattern separation, or the
ability to encode and recall small changes between similar inputs, in the dentate gyrus. Ablation
of neurogenesis in the SGZ prevented animals from correctly distinguishing between spatially
similar reward arms during a modified radial arm maze designed to test pattern separation.
Performance of depleted animals was similar to sham-operated controls if the arms were
separated by a greater distance82. Exercise induced increases in neurogenesis was recently shown
to improve spatial pattern separation in adult mice, and aged animals which were exposed to
exercise but resistant to increases in neurogenesis were subsequently resistant to exerciseinduced benefits in spatial memory83. These studies suggest that neurogenesis in the adult rodent
hippocampus contributes to spatial memory encoding.

1.5.3 Synaptic plasticity
Long-term potentiation, the ability of repeated afferent stimulation to produce a long-term
enhancement of synaptic transmission, has long been the leading hypothesis to explain how
synaptic plasticity influences hippocampal encoding of spatial memory84. This phenomenon was
first observed in the dentate gyrus anesthetized rabbits85 and has since been validated in other
model systems including mice84. One of the first studies using the cre-lox system for conditional
gene expression, specifically deleted N-methyl-D-aspartate receptors (NMDARs), which are
important mediators of LTP, in CA1 neurons to demonstrate that loss of LTP in the CA1
impaired spatial learning on the morris water maze86. A seminal study using an inhibitory
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avoidance paradigm, which creates a stable memory in rats after one trial, provided experimental
evidence that learning induces LTP in the hippocampus87.

1.6 Inflammation-induced CNS dysfunction in parenchyma
infection
*The following sections are adapted from material I wrote for our published review47

1.6.1 Viruses
Both DNA and RNA viruses of different families can infect the CNS, leading to the clinical
syndromes of meningitis, encephalitis, or meningoencephalitis. Many DNA viruses and few
RNA viruses replicate in the nucleus, establishing latency by integrating into the cellular DNA,
while most RNA viruses primarily replicate in the cytosol, and generally do not establish
latency88. Herpes simplex encephalitis (HSE), caused by the DNA virus herpes simplex virus
(HSV)-1, is the most common acute, sporadic encephalitis in the US and worldwide89.
Arthropod-born viruses, or arboviruses, are another important cause of encephalitis (Reviewed
in90). West Nile virus (WNV), a positive sense RNA flavivirus, is the most widely distributed
arbovirus worldwide, with cases reported on every continent but Antarctica91. The
pathophysiology, diagnosis, and management of acute HSE and WNV have been recently
reviewed92. Patients with viral encephalitis of any etiology typically present with fever,
headache, confusion and altered mental status but may also present with seizures or focal
neurological signs. Animal and human studies have demonstrated that both innate immune
responses and lymphocyte trafficking to the CNS are important mechanisms of virologic
control93,94. Neurological and neuropsychiatric sequelae can persist or develop following
encephalitis due to a variety of neurotropic pathogens, which has become a prioritized area of
research95. Patients surviving HSE or WNV encephalitis experience high rates of neurological
sequelae including memory impairment (60%), speech disorders (35%) and cognitive
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impairment (29%)96. Of the 90% of patients who survive WNV, about 50% experience cognitive
sequelae deficits including depression, fatigue, memory impairment or changes in executive
function that may persist for years97,98. Here, we will focus on mechanisms underlying
neurological sequelae in HSE and WNV encephalitis in individuals with intact immunity.
Increasing evidence suggests that developmental pathways regulating synaptic plasticity
by microglia and astrocytes can be reactivated during disease states. Alterations in synapse
homeostasis resulting from aberrant activation of glia may contribute to the cognitive
dysfunction seen in many neurocognitive disorders, including Autism Spectrum Disorders and a
variety of dementias including Alzheimer’s Disease (AD)99,100. The complement system, part of
innate immunity that initiates adaptive responses to clear virus peripherally101, influences
synapse homeostasis during development20,102 and can promote synapse elimination during
neurodegenerative and neuroinfectious diseases103,104. In a model of AD using J20 transgenic
mice which harbor a familial AD-mutant of human amyloid precursor protein105, C1q deposition
preceded synapse elimination and plaque formation, and mice deficient in complement signaling
had fewer phagocytic microglia and reduced synaptic elimination104. Loss of C1q also protected
animals from synaptic elimination and downstream behavioral phenotypes in a model of
dementia caused by deficiency of progranulin, a pleotropic protein that plays a major role in
genetic causes of frontotemporal dementia106. Progranulin-deficient microglia exhibit increased
lysosomal activity and complement production, leading to preferential elimination of inhibitory
neurons107. In a model of WNV-induced memory impairment, phagocytic microglia persisted for
weeks after viral clearance, and gene signatures associated with complement-mediated synapse
remodeling were elevated in the hippocampus, a CNS region responsible for memory103. Delayed
recovery from acute synapse loss correlated with poor spatial learning, and mice with fewer
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microglia (Il34–/–) or complement deficiency (C3–/– or C3ar–/–) were protected from virusinduced synaptic elimination103, suggesting aberrant microglial activation and complementmediated deletion of neuronal communication following viral encephalitis may result in
neurological sequelae seen in neurotropic virus-infected survivors.
While instituting intravenous acyclovir as the standard of care for HSE has greatly improved
survival rates108, patients surviving acute infection are at risk for clinical neurologic relapse and
the development of new neuropsychiatric symptoms including memory loss and epilepsy109. PCR
analysis of the CSF during relapse at times reveal an absence of CNS viral replication, leading to
the hypothesis that these relapses are in fact immune-mediated110. In recent years, numerous
studies and case reports have linked clinical relapses to the development of autoimmune
encephalitis, and in particular to anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis
(Reviewed in111). Administration of patient, but not control, CSF to hippocampal cultures leads
to a titer-dependent but reversible decrease in NMDAR density without altering the number of
synapses or the density of other synaptic proteins like PSD-95, GluR1, GluR2 receptor clusters
or GABA receptor112. Intracerebral infusion of patient CSF or purified IgG similarly increases
NMDAR internalization in vivo and alteration in glutamate homeostasis and signaling112,113.
Furthermore, these autoantibodies inhibited the development of long-term synaptic plasticity in
vitro114. The recent development of a rodent model for anti-NMDAR encephalitis demonstrates
that continuous infusion of patient autoantibodies can lead to behavioral deficits, providing a
platform for preclinical testing113. Whether autoantibodies develop due to molecular mimicry,
secondary to release of antigens following neuronal lysis, or as a primary mechanism of
neuroprotection by the immune system requires further study.
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1.6.2 Neurotropic parasites
CNS infections with certain neurotropic parasites are also known to cause alterations in host
behavior. Among the most well-known is Toxoplasma gondii, a common zoonotic parasite with
a worldwide seroprevalance between 30-70%. T. gondii, causes chronic CNS infection and
neuroinflammation after ingestion of oocysts in contaminated food or water115. Ingested oocysts
develop into fast-dividing tachyzoites that invade the gut epithelium and lamina propria,
replicate asexually through a process called endodyogeny, and then exit and infect myeloid cells,
which allow dissemination to multiple tissue sites in the body (including the eye, heart, liver,
lung, lymph nodes, muscles and CNS (Reviewed in116). The life cycle of T. gondii requires
infection of feline prey intermediate hosts whose ingestion leads to infection of feline definitive
hosts (Reviewed in117). Infection of intermediate host CNS appears to be a critical stage of the T.
gondii life cycle, ensuring successful predation via modifications in prey’s olfactory preferences
that reduce predator avoidance118,119. Epidemiologic studies of T. gondii infection in humans,
which may have evolved when human ancestors were still under feline predation120, similarly
link parasite seropositivity with alterations in olfactory preference and behavioral abnormalities
in immunocompetent individuals, the latter of which include those associated with
neurodegenerative and psychiatric diseases.
CNS invasion by T. gondii (Reviewed in121), leads to infection of all neural cell types,
most of which are promptly cleared of parasite via astrocyte and microglial expression of T cell
chemoattractants CCL5, CXCL9 and CXCL10, that recruit IFN-γ-expressing CD4+ and CD8+ T
cells directed at T. gondii antigens122. Neurons remain latently infected with slowly replicating
bradyzoites for the life of the host. In murine studies, behavioral effects of T. gondii are
associated with direct infection of cortical neurons and astrocytes with modification in their
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functions, including those that impact innate immunity and dopaminergic and glutamate
signaling123,124. Direct effects of T. gondii on neuronal function, including derailments of
neurotransmitter expression, modulation of calcium signaling, and loss of myelinated fibers,
MAP-2+ neurites and NeuN+ cells are all suggestive of parasite-mediated impairment or injury
(Reviewed in125). These effects are proposed to underlie a variety of behavioral alterations,
psychiatric diseases and certain neurodegenerative disorders observed in T. gondii–infected
hosts. However, aversion to cat urine is also observed in rodents after clearance of cysts126, and
low total cyst burdens and lack of specific neuronal tropism observed in infected brain regions
raise the important possibility that chronic T. gondii infection induces inflammatory-mediated
dysfunction that does not require the persistence of parasite.
The T. gondii-infected CNS exhibits increased astrocyte expression of TNF, IL-1a, and
IL-6127, each of which have been implicated in the regulation of neural correlates of memory
including adult neurogenesis, synaptic plasticity and modulation of long-term potentiation128–130.
Molecular interactions between dopaminergic and inflammatory cascades within neurons may
underlie behavioral alterations during chronic infection with T. gondii. NR4A transcription
factors NR4A1, NR4A2, and NR4A3 (also known as Nur77, Nurr1, and Nor1, respectively)
share similar DNA-binding properties and have been implicated in regulation of dopamine
neurotransmission genes131. Nurr1, in particular, induces tyrosine hydroxylase (TH) expression
during differentiation of dopaminergic neurons and plays a key role in the maintenance of the
dopaminergic system of the adult brain. Consistent with this, NR4A2 polymorphisms are
associated with a variety of neurologic and psychiatric disorders including Parkinson’s disease,
Lewy body dementia, addiction and attention deficit disorder132. Nurr1 and its co-regulating
factor, glycogen synthase kinase 3, recruits CoREST, a complex made of several proteins that
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assembles chromatin-modifying enzymes, also interacts with the transcription factor complex
NF-kB-p65, protecting dopaminergic neurons during LPS-induced inflammation by reducing
expression of inflammatory genes, including Tnf, NO and Il1b, in microglia and astrocytes133.
Nurr1-heterozygous mice show increased exploratory behavior and reduced anxiety that is
exacerbated by chronic infection with T. gondii compared with similarly infected wild-type
animals134. While there are no studies examining NR4A2 polymorphisms in psychiatric patients
chronically infected with T. gondii, cognitive deterioration among bipolar disorder patients
infected by T. gondii has been reported135. Genome-wide analyses may be a useful approach to
identify susceptibility genes that predispose individuals to development or worsening of affective
disorders after infection with T. gondii.

1.7 West Nile virus
1.7.1 Virology
West Nile virus (WNV) is a neurotropic, mosquito-borne flavivirus that cycles primarily
between birds and rodents. Humans and horses can incidentally serve as dead-end hosts when
bitten by an infected mosquito, but due to low levels of viremia do not contribute to the
transmission cycle for the virus. WNV is a member of the Flaviviridae family which includes
other viruses that cause a significant burden of disease worldwide including Dengue virus
(DENV)136, Japanese Encephalitis virus (JEV), Tick-borne encephalitis virus (TBEV) and Zika
virus (ZIKV, see section 1.9). Like other flaviviruses, WNV is a single-stranded positive-sense
RNA virus containing a single open reading frame. The translated polyprotein is cleaved by viral
and host proteases to generate three structural proteins (C, prM, and E) and seven non-structural
proteins (NS1, NS2A, NS2B, NS3, NS4a, NS4b)137.
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1.7.2 Epidemiology and clinical presentation
WNV was first isolated from a febrile patient in Uganda in 1947138 and was introduced to the US
in New York in 1999139. Since then the virus has spread across the US and is the leading cause of
domestically acquired arboviral disease with about 2,000 cases reported to the CDC every
year140. Most patients who become infected with WNV are asymptomatic or experience nonspecific flu-like symptoms that cause significant morbidity but remain undiagnosed141. A subset
of patients may experience severe and potentially fatal neuroinvasive disease including
encephalitis, meningitis, and/or flaccid paralysis142. Patients surviving West nile virus experience
significant morbidity due to the presence of persistent neurological sequelae which can last for
years98,143–150. A systematic review of the clinical literature revealed that muscle weakness,
fatigue, memory loss and depression are among the most commonly reported symptoms150.
Fatigue was present in 48-75% of patients after neuroinvasive disease and 48% of patients with
WNV fever150. Memory loss was present in up to 59% of patients for up to 8 years following
infection with WNV150.

1.8 Zika virus
1.8.1 Epidemiology and clinical presentation
Zika virus was first isolated in 1947 from a rhesus monkey in the Zika forest of Uganda151. In
2007 there was an outbreak in the Yap Island of Micronesia primarily characterized by rash,
fever, arthralgia and conjunctivitis which represented the first occasion of spread outside of
Africa and Asia152. In 2013 and 2014 another major outbreak of Zika virus occurred, this time
associated with Guillain-Barre syndrome, an autoimmune flaccid paralysis153. In 2016 the Zika
virus epidemic was named a Public Health Emergency of International Concern (PHEIC) due to
the clustered reports of microcephaly and GBS cases in Brazil and other countries154.
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The recent epidemic has revealed multiple outcomes of Zika virus infection causing
human disease. Congenital ZIKV exposure can cause multiple abnormalities, now clinically
defined as Congenital Zika Syndrome, including severe microcephaly, cortical malformation,
subcortical or basal ganglia calcifications, and hypertonia155. In addition to Guillain-Barre
Syndrome (GBS), which was associated with Zika virus infection in French Polynesia153, a range
of other neurological complications in adults infected with Zika virus have been reported, and
the long-term outcomes for patients surviving this emerging neurotropic virus remain
unknown156–162. Animal studies have demonstrated increased neurotropism and neurovirulence of
African lineage strains, particularly in the CNS. Some have suggested that outbreaks may have
occurred, but went unnoticed due to the low capacity for detecting and reporting emerging
threats in much of the continent163. Indeed, a retrospective cohort study in Nigeria in 2012
identified 340 cases of microcephaly among 3196 infants enrolled (10.6%), which at the time
was attributed to suspected CMV164.

1.8.2 Neurotropism
Zika virus can infect human neural progenitor cells derived from human induced pleuripotent
stem cells (hiPSCs), leading to increased cell death and cell cycle disturbance165 which prevents
neurosphere proliferation and brain organoid growth in vitro166. In triple knock out mice
deficient in Irf3, Irf5, and Irf7, retro-orbital injection of a Cambodian isolate of ZIKV led to
infection of adult neural progenitor cells in neurogenic zones leading to caspase-3 activation and
apoptosis167. Another study found early infection of GFAP+ astrocytes and mature neurons in the
CNS after intraperitoneal (ip) injection of wildtype pups with a Cambodian isolate on the day of
birth (P0), with sparse infection of neural progenitor cells at this developmental stage168. Another
group infected WT mice at P7 or P21 by intracranial injection with ZIKV MR766 and found
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immunoreactivity for the apoptotic marker cleaved caspase 3 (CC3) to colocalize with NeuN, a
marker of mature neurons169. Finally, a recent study of congenital Zika virus infection in pigtail
macaques found decreased numbers of neural progenitors in the neurogenic SGZ and SVZ as
well as increases in astrocytes in virus-exposed fetal tissue harvested by caesarean section within
one month of their due date170.
High levels of ZIKV RNA and infectious virus were detected in the spinal cord and
brains of 4-6 week old Ifnar1-/- mice infected with a ZIKV isolate from French Polynesia171.
ZIKV non-structural protein 5 (NS5) targets human STAT2 for proteasome-dependent
degradation, which allows it to evade the Type I interferon response and cause disease172,173. NS5
does not bind mouse STAT2, which could explain the lack of disease in wild-type mice173.
Indeed, in Stat2-/- mice, subcutaneous infection with African lineage strains (Uganda MR766
and Dakar 41519) led to high levels of virus in the brain, robust induction of chemokines and
cytokines, and lethality by 7 days post infection. WT animals infected with the same strains did
not lose weight or succumb to the infection174.

1.9 References
1.
2.
3.
4.
5.
6.

Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local
brain injury in vivo. Nat Neurosci. 2005;8(6):752-758. doi:10.1038/nn1472.
Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for
normal brain development. Science. 2011;333(6048):1456-1458.
doi:10.1126/science.1202529.
Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia Sculpt Postnatal Neural Circuits
in an Activity and Complement-Dependent Manner. Neuron. 2012;74(4):691-705.
doi:10.1016/j.neuron.2012.03.026.
Marı́n-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia
Promote the Death of Developing Purkinje Cells. Neuron. 2004;41(4):535-547.
doi:10.1016/S0896-6273(04)00069-8.
Sierra A, Encinas JM, Deudero JJP, et al. Microglia Shape Adult Hippocampal
Neurogenesis through Apoptosis-Coupled Phagocytosis. Cell Stem Cell. 2010;7(4):483495. doi:10.1016/J.STEM.2010.08.014.
Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of
21

7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.

neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):42164233. doi:10.1523/JNEUROSCI.3441-12.2013.
Wolf SA, Steiner B, Akpinarli A, et al. CD4-positive T lymphocytes provide a
neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol.
2009;182(7):3979-3984. doi:10.4049/jimmunol.0801218.
Derecki NC, Cardani AN, Yang CH, et al. Regulation of learning and memory by
meningeal immunity: a key role for IL-4. J Exp Med. 2010;207(5):1067-1080.
doi:10.1084/jem.20091419.
Radjavi A, Smirnov I, Kipnis J. Brain antigen-reactive CD4+ T cells are sufficient to
support learning behavior in mice with limited T cell repertoire. Brain Behav Immun.
2014;35:58-63. doi:10.1016/J.BBI.2013.08.013.
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central
nervous system lymphatic vessels. Nature. 2015;523(7560):337-341.
doi:10.1038/nature14432.
Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia
derive from primitive macrophages. Science. 2010;330(6005):841-845.
doi:10.1126/science.1194637.
Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate
from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518(7540):547-551.
doi:10.1038/nature13989.
Goldmann T, Wieghofer P, Jordão MJC, et al. Origin, fate and dynamics of macrophages
at central nervous system interfaces. Nat Immunol. 2016;17(7):797-805.
doi:10.1038/ni.3423.
Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev
Immunol. 2017;18(4):225-242. doi:10.1038/nri.2017.125.
Butovsky O, Jedrychowski MP, Moore CS, et al. Identification of a unique TGF-β–
dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131143. doi:10.1038/nn.3599.
Goldmann T, Wieghofer P, Jordão MJC, et al. Origin, fate and dynamics of macrophages
at central nervous system interfaces. Nat Immunol. 2016;17(7):797-805.
doi:10.1038/ni.3423.
Greter M, Lelios I, Pelczar P, et al. Stroma-derived interleukin-34 controls the
development and maintenance of langerhans cells and the maintenance of microglia.
Immunity. 2012;37(6):1050-1060. doi:10.1016/j.immuni.2012.11.001.
Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R
required for the development of Langerhans cells and microglia. Nat Immunol.
2012;13(8):753-760. doi:10.1038/ni.2360.
Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic
surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314-1318.
doi:10.1126/science.1110647.
Tremblay M-È, Lowery RL, Majewska AK. Microglial Interactions with Synapses Are
Modulated by Visual Experience. Dalva M, ed. PLoS Biol. 2010;8(11):e1000527.
doi:10.1371/journal.pbio.1000527.
Hickman SE, Kingery ND, Ohsumi TK, et al. The microglial sensome revealed by direct
RNA sequencing. Nat Neurosci. 2013;16(12):1896-1905. doi:10.1038/nn.3554.
Miyamoto A, Wake H, Ishikawa AW, et al. Microglia contact induces synapse formation
22

23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.

in developing somatosensory cortex. Nat Commun. 2016;7:12540.
doi:10.1038/ncomms12540.
Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse
formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596-1609.
doi:10.1016/j.cell.2013.11.030.
Vainchtein ID, Chin G, Cho FS, et al. Astrocyte-derived interleukin-33 promotes
microglial synapse engulfment and neural circuit development. Science.
2018;359(6381):1269-1273. doi:10.1126/science.aal3589.
Tay TL, Mai D, Dautzenberg J, et al. A new fate mapping system reveals contextdependent random or clonal expansion of microglia. Nat Neurosci. 2017;20(6):793-803.
doi:10.1038/nn.4547.
Füger P, Hefendehl JK, Veeraraghavalu K, et al. Microglia turnover with aging and in an
Alzheimer’s model via long-term in vivo single-cell imaging. Nat Neurosci.
2017;20(10):1371-1376. doi:10.1038/nn.4631.
Grabert K, Michoel T, Karavolos MH, et al. Microglial brain region−dependent diversity
and selective regional sensitivities to aging. Nat Neurosci. 2016;19(3):504-516.
doi:10.1038/nn.4222.
Bonni A, Sun Y, Nadal-Vicens M, et al. Regulation of gilogenesis in the central nervous
system by the jak-stat signaling pathway. Science (80- ). 1997;278(October):477-483.
He F, Ge W, Martinowich K, et al. A positive autoregulatory loop of Jak-STAT signaling
controls the onset of astrogliogenesis. Nat Neurosci. 2005;8(5):616-625.
doi:10.1038/nn1440.
Tien A-C, Tsai H-H, Molofsky A V., et al. Regulated temporal-spatial astrocyte precursor
cell proliferation involves BRAF signalling in mammalian spinal cord. Development.
2012;139(14):2477-2487. doi:10.1242/dev.077214.
Tsai HH, Li H, Fuentealba LC, et al. Regional astrocyte allocation regulates CNS
synaptogenesis and repair. Science (80- ). 2012;337(6092):358-362.
doi:10.1126/science.1222381.
Ge W-P, Miyawaki A, Gage FH, Jan YN, Jan LY. Local generation of glia is a major
astrocyte source in postnatal cortex. Nature. 2012;484(7394):376-380.
doi:10.1038/nature10959.
Bandeira F, Lent R, Herculano-Houzel S. Changing numbers of neuronal and nonneuronal cells underlie postnatal brain growth in the rat. Proc Natl Acad Sci U S A.
2009;106(33):14108-14113. doi:10.1073/pnas.0804650106.
Abbott NJ, Rönnbäck L, Hansson E. Astrocyte–endothelial interactions at the blood–brain
barrier. Nat Rev Neurosci. 2006;7(1):41-53. doi:10.1038/nrn1824.
Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat
Rev Neurosci. 2013;14(5):311-321. doi:10.1038/nrn3484.
Seifert G, Huttmann K, Binder DK, et al. Analysis of Astroglial K+ Channel Expression
in the Developing Hippocampus Reveals a Predominant Role of the Kir4.1 Subunit. J
Neurosci. 2009;29(23):7474-7488. doi:10.1523/JNEUROSCI.3790-08.2009.
Gourine A V, Kasymov V, Marina N, et al. Astrocytes control breathing through pHdependent release of ATP. Science. 2010;329(5991):571-575.
doi:10.1126/science.1190721.
Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem
cells. Nature. 2002;417(6884):39-44. doi:10.1038/417039a.
23

39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.

50.

51.

52.
53.
54.
55.
56.

Molofsky A V., Kelley KW, Tsai H-H, et al. Astrocyte-encoded positional cues maintain
sensorimotor circuit integrity. Nature. 2014;509(7499):189-194. doi:10.1038/nature13161.
Morquette P, Verdier D, Kadala A, et al. An astrocyte-dependent mechanism for neuronal
rhythmogenesis. Nat Neurosci. 2015;18(6):844-854. doi:10.1038/nn.4013.
Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci.
2012;32(18):6391-6410. doi:10.1523/JNEUROSCI.6221-11.2012.
Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are
induced by activated microglia. Nature. 2017;541(7638):481-487.
doi:10.1038/nature21029.
Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci.
2016;19(8):987-991. doi:10.1038/nn.4338.
Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation aids central nervous
system axon regeneration. Nature. 2016;532(7598):195-200. doi:10.1038/nature17623.
Hayakawa K, Esposito E, Wang X, et al. Transfer of mitochondria from astrocytes to
neurons after stroke. Nature. 2016;535(7613):551-555. doi:10.1038/nature18928.
Jo S, Yarishkin O, Hwang YJ, et al. GABA from reactive astrocytes impairs memory in
mouse models of Alzheimer’s disease. Nat Med. 2014;20(8):886-896.
doi:10.1038/nm.3639.
Klein RS, Garber C, Howard N. Infectious immunity in the central nervous system and
brain function. Nat Immunol 2017 182. 2017;18(2):132. doi:10.1038/ni.3656.
Morga E, Faber C, Heuschling P. Cultured astrocytes express regional heterogeneity of
the immunoreactive phenotype under basal conditions and after γ-IFN induction. J
Neuroimmunol. 1998;87(1):179-184. doi:10.1016/S0165-5728(98)00099-X.
Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE. Regional Heterogeneity and
Diversity in Cytokine and Chemokine Production by Astroglia: Differential Responses to
HIV-1 Tat, gp120 and Morphine Revealed by Multiplex Analysis. J Proteome Res J
Proteome Res April. 2010;5(94):1795-1804. doi:10.1021/pr900926n.
Wacher C, Müller M, Hofer MJ, et al. Coordinated regulation and widespread cellular
expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the
central nervous system after infection with distinct viruses. J Virol. 2007;81(2):860-871.
doi:10.1128/JVI.01167-06.
Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. Differential innate
immune response programs in neuronal subtypes determine susceptibility to infection in
the brain by positive-stranded RNA viruses. Nat Med. 2013;19(4):458-464.
doi:10.1038/nm.3108.
Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous
system. Science. 2016;353(6301):766-771. doi:10.1126/science.aag2638.
Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive
dysfunction: Implications for therapeutic vaccination for schizophrenia and other
psychiatric conditions. 2004;101(21):8180-8185.
Brynskikh A, Warren T, Zhu J, Kipnis J. Adaptive immunity affects learning behavior in
mice. Brain Behav Immun. 2008;22(6):861-869. doi:10.1016/J.BBI.2007.12.008.
Radjavi A, Smirnov I, Derecki N, Kipnis J. Dynamics of the meningeal CD4+ T-cell
repertoire are defined by the cervical lymph nodes and facilitate cognitive task
performance in mice. Mol Psychiatry. 2014;19(5):531-532. doi:10.1038/mp.2013.79.
Ziv Y, Ron N, Butovsky O, et al. Immune cells contribute to the maintenance of
24

57.
58.
59.
60.

61.
62.
63.
64.
65.

66.
67.
68.
69.
70.
71.

neurogenesis and spatial learning abilities in adulthood. Nat Neurosci. 2006;9(2):268-275.
doi:10.1038/nn1629.
Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains
brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991-999.
doi:10.1084/jem.20142290.
Klein RS, Lin E, Zhang B, et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and
control of West Nile virus encephalitis. J Virol. 2005;79(17):11457-11466.
doi:10.1128/JVI.79.17.11457-11466.2005.
Durrant DM, Robinette ML, Klein RS. IL-1R1 is required for dendritic cell-mediated T
cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med.
2013;210(3):503-516. doi:10.1084/jem.20121897.
McCandless EE, Zhang B, Diamond MS, Klein RS. CXCR4 antagonism increases T cell
trafficking in the central nervous system and improves survival from West Nile virus
encephalitis. Proc Natl Acad Sci U S A. 2008;105(32):11270-11275.
doi:10.1073/pnas.0800898105.
Cupovic J, Onder L, Gil-Cruz C, et al. Central Nervous System Stromal Cells Control
Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation. Immunity.
2016;44(3):622-633. doi:10.1016/j.immuni.2015.12.022.
Kim J V., Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes
fatal CNS vascular injury during acute viral meningitis. Nature. 2009;457(7226):191-195.
doi:10.1038/nature07591.
Herz J, Johnson KR, McGavern DB. Therapeutic antiviral T cells noncytopathically clear
persistently infected microglia after conversion into antigen-presenting cells. J Exp Med.
2015;212(8):1153-1169. doi:10.1084/jem.20142047.
Most RG v. d. Prolonged presence of effector-memory CD8 T cells in the central nervous
system after dengue virus encephalitis. Int Immunol. 2003;15(1):119-125.
doi:10.1093/intimm/dxg009.
Wakim LM, Woodward-davis A, Bevan MJ. Memory T cells persisting within the brain
after local infection show functional adaptations to their tissue of residence. 2010.
doi:10.1073/pnas.1010201107//DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1010201107.
Graham JB, Da Costa A, Lund JM. Regulatory T cells shape the resident memory T cell
response to virus infection in the tissues. J Immunol. 2014;192(2):683-690.
doi:10.4049/jimmunol.1202153.
Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA. Persistence of virus-specific
immune responses in the central nervous system of mice after West Nile virus infection.
BMC Immunol. 2011;12(1):6. doi:10.1186/1471-2172-12-6.
Hawke S, Stevenson PG, Freeman S, Bangham CR. Long-term persistence of activated
cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med.
1998;187(10):1575-1582. doi:10.1084/JEM.187.10.1575.
Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune
defence. Nat Rev Immunol. 2016;16(2):79-89. doi:10.1038/nri.2015.3.
Schenkel JM, Fraser K a, Beura LK, Pauken KE, Vezys V, Masopust D. Resident memory
CD8 T cells trigger protective innate and adaptive immune responses. Science (80- ).
2014;346(6205):98-101. doi:10.1126/science.1254536.
Shiow LR, Rosen DB, Brdičková N, et al. CD69 acts downstream of interferon-α/β to
25

72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.

inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540544. doi:10.1038/nature04606.
Mackay LK, Braun A, Macleod BL, et al. Cutting edge: CD69 interference with
sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J
Immunol. 2015;194(5):2059-2063. doi:10.4049/jimmunol.1402256.
Casey KA, Fraser KA, Schenkel JM, et al. Antigen-independent differentiation and
maintenance of effector-like resident memory T cells in tissues. J Immunol.
2012;188(10):4866-4875. doi:10.4049/jimmunol.1200402.
Steinbach K, Vincenti I, Kreutzfeldt M, et al. Brain-resident memory T cells represent an
autonomous cytotoxic barrier to viral infection. J Exp Med. 2016;213(8):1571-1587.
doi:10.1084/jem.20151916.
Wakim LM, Woodward-Davis A, Liu R, et al. The molecular signature of tissue resident
memory CD8 T cells isolated from the brain. J Immunol. 2012;189(7):3462-3471.
doi:10.4049/jimmunol.1201305.
Rebola N, Carta M, Mulle C. Operation and plasticity of hippocampal CA3 circuits:
implications for memory encoding. Nat Rev Neurosci. 2017;18(4):208-220.
doi:10.1038/nrn.2017.10.
Newman EL, Hasselmo ME. CA3 Sees the Big Picture while Dentate Gyrus Splits Hairs.
Neuron. 2014;81(2):226-228. doi:10.1016/J.NEURON.2014.01.004.
Neunuebel JP, Knierim JJ. CA3 Retrieves Coherent Representations from Degraded Input:
Direct Evidence for CA3 Pattern Completion and Dentate Gyrus Pattern Separation.
Neuron. 2014;81(2):416-427. doi:10.1016/J.NEURON.2013.11.017.
Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult
hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci.
2010;11(5):339-350. doi:10.1038/nrn2822.
Imayoshi I, Sakamoto M, Ohtsuka T, et al. Roles of continuous neurogenesis in the
structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11(10):11531161. doi:10.1038/nn.2185.
Yau S, Li A, So K-F. Involvement of Adult Hippocampal Neurogenesis in Learning and
Forgetting. Neural Plast. 2015;2015:717958. doi:10.1155/2015/717958.
Clelland CD, Choi M, Romberg C, et al. A functional role for adult hippocampal
neurogenesis in spatial pattern separation. Science. 2009;325(5937):210-213.
doi:10.1126/science.1173215.
Creer DJ, Romberg C, Saksida LM, van Praag H, Bussey TJ. Running enhances spatial
pattern separation in mice. Proc Natl Acad Sci U S A. 2010;107(5):2367-2372.
doi:10.1073/pnas.0911725107.
Neves G, Cooke SF, Bliss TVP. Synaptic plasticity, memory and the hippocampus: a
neural network approach to causality. Nat Rev Neurosci. 2008;9(1):65-75.
doi:10.1038/nrn2303.
Bliss TVP, Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area
of the anaesthetized rabbit following stimulation of the perforant path. J Physiol.
1973;232(2):331-356. doi:10.1113/jphysiol.1973.sp010273.
Tsien JZ, Huerta PT, Tonegawa S. The Essential Role of Hippocampal CA1 NMDA
Receptor–Dependent Synaptic Plasticity in Spatial Memory. Cell. 1996;87(7):1327-1338.
doi:10.1016/S0092-8674(00)81827-9.
Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation
26

88.
89.
90.
91.
92.
93.
94.
95.
96.
97.

98.
99.
100.
101.
102.
103.

in the hippocampus. Science. 2006;313(5790):1093-1097. doi:10.1126/science.1128134.
Mettenleiter TC. Breaching the Barrier—The Nuclear Envelope in Virus Infection. J Mol
Biol. 2016;428(10):1949-1961. doi:10.1016/J.JMB.2015.10.001.
Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in
their clinical presentations in England: a multicentre, population-based prospective study.
Lancet Infect Dis. 2010;10(12):835-844. doi:10.1016/S1473-3099(10)70222-X.
Salimi H, Cain MD, Klein RS. Encephalitic Arboviruses: Emergence, Clinical
Presentation, and Neuropathogenesis. Neurotherapeutics. 2016;13(3):514-534.
doi:10.1007/s13311-016-0443-5.
Kramer LD, Styer LM, Ebel GD. A Global Perspective on the Epidemiology of West Nile
Virus. Annu Rev Entomol. 2008;53(1):61-81.
doi:10.1146/annurev.ento.53.103106.093258.
Bradshaw MJ, Venkatesan A. Herpes Simplex Virus-1 Encephalitis in Adults:
Pathophysiology, Diagnosis, and Management. Neurotherapeutics. 2016;13(3):493-508.
doi:10.1007/s13311-016-0433-7.
Altfeld M, Gale Jr M. Innate immunity against HIV-1 infection. Nat Immunol.
2015;16(6):554-562. doi:10.1038/ni.3157.
Armangue T, Moris G, Cantarín-Extremera V, et al. Autoimmune post-herpes simplex
encephalitis of adults and teenagers. Neurology. 2015;85(20):1736-1743.
doi:10.1212/WNL.0000000000002125.
John CC, Carabin H, Montano SM, Bangirana P, Zunt JR, Peterson PK. Global research
priorities for infections that affect the nervous system. Nature. 2015;527(7578):S178S186. doi:10.1038/nature16033.
STAHL JP, MAILLES A, De BROUCKER T, Group the SC and I. Herpes simplex
encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol
Infect. 2012;140(2):372-381. doi:10.1017/S0950268811000483.
Garcia MN, Hause AM, Walker CM, Orange JS, Hasbun R, Murray KO. Evaluation of
Prolonged Fatigue Post–West Nile Virus Infection and Association of Fatigue with
Elevated Antiviral and Proinflammatory Cytokines. Viral Immunol. 2014;27(7):327-333.
doi:10.1089/vim.2014.0035.
Sadek JR, Pergam S a, Harrington J a, et al. Persistent neuropsychological impairment
associated with West Nile virus infection. J Clin Exp Neuropsychol. 2010;32(1):81-87.
doi:10.1080/13803390902881918.
Guerreiro R, Wojtas A, Bras J, et al. TREM2 Variants in Alzheimer’s Disease. N Engl J
Med. 2013;368(2):117-127. doi:10.1056/NEJMoa1211851.
Chung W-S, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive
impairment in disease? Nat Neurosci. 2015;18(11):1539-1545. doi:10.1038/nn.4142.
Mehlhop E, Diamond MS. Protective immune responses against West Nile virus are
primed by distinct complement activation pathways. J Exp Med. 2006;203(5):1371-1381.
doi:10.1084/jem.20052388.
Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia Sculpt Postnatal Neural Circuits
in an Activity and Complement-Dependent Manner. Neuron. 2012;74(4):691-705.
doi:10.1016/J.NEURON.2012.03.026.
Vasek MJ, Garber C, Dorsey D, et al. A complement–microglial axis drives synapse loss
during virus-induced memory impairment. Nature. 2016;534(7608):538-543.
doi:10.1038/nature18283.
27

104. Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early
synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712-716.
doi:10.1126/science.aad8373.
105. Mucke L, Masliah E, Yu GQ, et al. High-level neuronal expression of abeta 1-42 in wildtype human amyloid protein precursor transgenic mice: synaptotoxicity without plaque
formation. J Neurosci. 2000;20(11):4050-4058. doi:10.1523/JNEUROSCI.20-1104050.2000.
106. Woollacott IOC, Rohrer JD. The clinical spectrum of sporadic and familial forms of
frontotemporal dementia. J Neurochem. 2016;138:6-31. doi:10.1111/jnc.13654.
107. Lui H, Zhang J, Makinson SR, et al. Progranulin Deficiency Promotes Circuit-Specific
Synaptic Pruning by Microglia via Complement Activation. Cell. 2016;165(4):921-935.
doi:10.1016/j.cell.2016.04.001.
108. Sköldenberg B, Alestig K, Burman L, et al. ACYCLOVIR VERSUS VIDARABINE IN
HERPES SIMPLEX ENCEPHALITIS. Lancet. 1984;324(8405):707-711.
doi:10.1016/S0140-6736(84)92623-0.
109. Sili U, Kaya A, Mert A, et al. Herpes simplex virus encephalitis: clinical manifestations,
diagnosis and outcome in 106 adult patients. J Clin Virol. 2014;60(2):112-118.
doi:10.1016/j.jcv.2014.03.010.
110. De Tiege X, Rozenberg F, Des Portes V, et al. Herpes simplex encephalitis relapses in
children: Differentiation of two neurologic entities. Neurology. 2003;61(2):241-243.
doi:10.1212/01.WNL.0000073985.71759.7C.
111. Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci.
2015;1338(1):94-114. doi:10.1111/nyas.12553.
112. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of antiNMDA receptor encephalitis. J Neurosci. 2010;30(17):5866-5875.
doi:10.1523/JNEUROSCI.0167-10.2010.
113. Planagumà J, Leypoldt F, Mannara F, et al. Human N-methyl D-aspartate receptor
antibodies alter memory and behaviour in mice. Brain. 2015;138(Pt 1):94-109.
doi:10.1093/brain/awu310.
114. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA
and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain. 2012;135(Pt 5):1606-1621.
doi:10.1093/brain/aws092.
115. Guo M, Mishra A, Buchanan RL, et al. A Systematic Meta-Analysis of Toxoplasma
gondii Prevalence in Food Animals in the United States. Foodborne Pathog Dis.
2016;13(3):109-118. doi:10.1089/fpd.2015.2070.
116. Ueno N, Lodoen MB. From the blood to the brain: avenues of eukaryotic pathogen
dissemination to the central nervous system. Curr Opin Microbiol. 2015;26:53-59.
doi:10.1016/J.MIB.2015.05.006.
117. White MW, Radke JR, Radke JB. T oxoplasma development - turn the switch on or off?
Cell Microbiol. 2014;16(4):466-472. doi:10.1111/cmi.12267.
118. Flegr J, Lenochová P, Hodný Z, Vondrová M. Fatal Attraction Phenomenon in Humans –
Cat Odour Attractiveness Increased for Toxoplasma-Infected Men While Decreased for
Infected Women. Webster JP, ed. PLoS Negl Trop Dis. 2011;5(11):e1389.
doi:10.1371/journal.pntd.0001389.
119. Vyas A, Kim S-K, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes
induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors.
28

120.
121.
122.
123.
124.
125.
126.

127.
128.

129.

130.

131.

132.
133.

Proc Natl Acad Sci U S A. 2007;104(15):6442-6447. doi:10.1073/pnas.0608310104.
Poirotte C, Kappeler PM, Ngoubangoye B, Bourgeois S, Moussodji M, Charpentier MJE.
Morbid attraction to leopard urine in Toxoplasma-infected chimpanzees. Curr Biol.
2016;26(3):R98-R99. doi:10.1016/J.CUB.2015.12.020.
Blanchard N, Dunay IR, Schlüter D. Persistence of Toxoplasma gondii in the central
nervous system: a fine-tuned balance between the parasite, the brain and the immune
system. Parasite Immunol. 2015;37(3):150-158. doi:10.1111/pim.12173.
Landrith TA, Harris TH, Wilson EH. Characteristics and critical function of CD8+ T cells
in the Toxoplasma-infected brain. Semin Immunopathol. 2015;37(3):261-270.
doi:10.1007/s00281-015-0487-3.
Cabral CM, Tuladhar S, Dietrich HK, et al. Neurons are the Primary Target Cell for the
Brain-Tropic Intracellular Parasite Toxoplasma gondii. Denkers EY, ed. PLOS Pathog.
2016;12(2):e1005447. doi:10.1371/journal.ppat.1005447.
David CN, Frias ES, Szu JI, et al. GLT-1-Dependent Disruption of CNS Glutamate
Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii.
Pletnikov M, ed. PLOS Pathog. 2016;12(6):e1005643. doi:10.1371/journal.ppat.1005643.
Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii -induced neuronal alterations.
Parasite Immunol. 2015;37(3):159-170. doi:10.1111/pim.12157.
Ingram WM, Goodrich LM, Robey EA, Eisen MB. Mice Infected with Low-Virulence
Strains of Toxoplasma gondii Lose Their Innate Aversion to Cat Urine, Even after
Extensive Parasite Clearance. Wilson EH, ed. PLoS One. 2013;8(9):e75246.
doi:10.1371/journal.pone.0075246.
Mahmoudvand H, Ziaali N, Ghazvini H, et al. Toxoplasma gondii Infection Promotes
Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c
Mice. Inflammation. 2016;39(1):405-412. doi:10.1007/s10753-015-0262-6.
Riazi K, Galic MA, Kentner AC, Reid AY, Sharkey KA, Pittman QJ. Microgliadependent alteration of glutamatergic synaptic transmission and plasticity in the
hippocampus during peripheral inflammation. J Neurosci. 2015;35(12):4942-4952.
doi:10.1523/JNEUROSCI.4485-14.2015.
Wu MD, Montgomery SL, Rivera-Escalera F, Olschowka JA, O’Banion MK. Sustained
IL-1β expression impairs adult hippocampal neurogenesis independent of IL-1 signaling
in nestin+ neural precursor cells. Brain Behav Immun. 2013;32:9-18.
doi:10.1016/J.BBI.2013.03.003.
del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky HO. A cytokine network
involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term
potentiation and learning. Brain Behav Immun. 2013;33:15-23.
doi:10.1016/J.BBI.2013.05.011.
Eells JB, Wilcots J, Sisk S, Guo-Ross SX. NR4A Gene Expression Is Dynamically
Regulated in the Ventral Tegmental Area Dopamine Neurons and Is Related to Expression
of Dopamine Neurotransmission Genes. J Mol Neurosci. 2012;46(3):545-553.
doi:10.1007/s12031-011-9642-z.
Grimes DA, Han F, Panisset M, et al. Translated mutation in the Nurr1 gene as a cause for
Parkinson’s disease. Mov Disord. 2006;21(7):906-909. doi:10.1002/mds.20820.
Lallier SW, Graf AE, Waidyarante GR, Rogers LK. Nurr1 expression is modified by
inflammation in microglia. Neuroreport. 2016;27(15):1120-1127.
doi:10.1097/WNR.0000000000000665.
29

134. Eells JB, Varela-Stokes A, Guo-Ross SX, et al. Chronic Toxoplasma gondii in Nurr1-Null
Heterozygous Mice Exacerbates Elevated Open Field Activity. Wilson EH, ed. PLoS One.
2015;10(4):e0119280. doi:10.1371/journal.pone.0119280.
135. Hamdani N, Daban-Huard C, Lajnef M, et al. Cognitive deterioration among bipolar
disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J
Affect Disord. 2015;179:161-166. doi:10.1016/J.JAD.2015.03.038.
136. Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis
from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712-723.
doi:10.1016/S1473-3099(16)00026-8.
137. Brinton MA. The Molecular Biology of West Nile Virus: A New Invader of the Western
Hemisphere. Annu Rev Microbiol. 2002;56(1):371-402.
doi:10.1146/annurev.micro.56.012302.160654.
138. Hughes TP, Paul JH, Smithburn KC, Burke AW. A Neurotropic Virus Isolated from the
Blood of a Native of Uganda 1. Am J Trop Med Hyg. 1940;s1-20(4):471-492.
doi:10.4269/ajtmh.1940.s1-20.471.
139. Nash D, Mostashari F, Fine A, et al. The Outbreak of West Nile Virus Infection in the
New York City Area in 1999. N Engl J Med. 2001;344(24):1807-1814.
doi:10.1056/NEJM200106143442401.
140. Burakoff A, Lehman J, Fischer M, Staples JE, Lindsey NP. West Nile Virus and Other
Nationally Notifiable Arboviral Diseases — United States, 2016. MMWR Morb Mortal
Wkly Rep. 2018;67(1):13-17. doi:10.15585/mmwr.mm6701a3.
141. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile Fever Characteristics
among Viremic Persons Identified through Blood Donor Screening. J Infect Dis.
2010;202(9):1354-1361. doi:10.1086/656602.
142. Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann
Neurol. 2006;60(3):286-300. doi:10.1002/ana.20959.
143. Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological
outcomes of West Nile virus infection. Clin Infect Dis. 2006;43(6):723-730.
doi:10.1086/506939.
144. Loeb M. Prognosis after West Nile Virus Infection. Ann Intern Med. 2008;149(4):232.
doi:10.7326/0003-4819-149-4-200808190-00004.
145. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West
Nile virus infection. JAMA. 2003;290(4):511-515. doi:10.1001/jama.290.4.511.
146. Klee AL, Maldin B, Edwin B, et al. Long-Term Prognosis for Clinical West Nile Virus
Infection. 2004;10(8):8-14.
147. Patnaik JL, Harmon H, Vogt RL. Human West Nile Virus Infections ,. 2006;12(7):11291131.
148. Haaland KY, Sadek J, Pergam S, et al. Mental status after West Nile virus infection.
Emerg Infect Dis. 2006;12(8):1260-1262. doi:10.3201/eid1208.060097.
149. Murray K, Walker C, Herrington E, et al. Persistent Infection with West Nile Virus Years
after Initial Infection. J Infect Dis. 2010;201(1):2-4. doi:10.1086/648731.
150. Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a
systematic review. Lancet Infect Dis. 2015;15(8):951-959. doi:10.1016/S14733099(15)00134-6.
151. Dick GW., Kitchen S., Haddow A. Zika Virus (I). Isolations and serological specificity.
Trans R Soc Trop Med Hyg. 1952;46(5):509-520. doi:10.1016/0035-9203(52)90042-4.
30

152. Duffy MR, Chen T-H, Hancock WT, et al. Zika Virus Outbreak on Yap Island, Federated
States of Micronesia. N Engl J Med. 2009;360(24):2536-2543.
doi:10.1056/NEJMoa0805715.
153. Cao-Lormeau V-M, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated
with Zika virus infection in French Polynesia: a case-control study. Lancet.
2016;387(10027):1531-1539. doi:10.1016/S0140-6736(16)00562-6.
154. WHO | WHO statement on the first meeting of the International Health Regulations
(2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in
neurological disorders and neonatal malformations. WHO. 2016.
http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committeezika/en/. Accessed April 18, 2018.
155. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the Pattern of Anomalies in
Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr. 2017;171(3):288.
doi:10.1001/jamapediatrics.2016.3982.
156. Roth W, Tyshkov C, Thakur K, Vargas W. Encephalomyelitis Following Definitive Zika
Virus Infection. Neurol Neuroimmunol neuroinflammation. 2017;4(4):e349.
doi:10.1212/NXI.0000000000000349.
157. Rozé B, Najioullah F, Signate A, et al. Zika virus detection in cerebrospinal fluid from
two patients with encephalopathy, Martinique, February 2016. Eurosurveillance.
2016;21(16):30205. doi:10.2807/1560-7917.ES.2016.21.16.30205.
158. Carteaux G, Maquart M, Bedet A, et al. Zika Virus Associated with Meningoencephalitis.
N Engl J Med. 2016;374(16):1595-1596. doi:10.1056/NEJMc1602964.
159. Soares CN, Brasil P, Carrera RM, et al. Fatal encephalitis associated with Zika virus
infection in an adult. J Clin Virol. 2016;83:63-65. doi:10.1016/J.JCV.2016.08.297.
160. Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection.
Lancet. 2016;387(10026):1481. doi:10.1016/S0140-6736(16)00644-9.
161. Muñoz LS, Parra B, Pardo CA. Neurological Implications of Zika Virus Infection in
Adults. J Infect Dis. 2017;216(suppl_10):S897-S905. doi:10.1093/infdis/jix511.
162. Mehta R, Soares CN, Medialdea-Carrera R, et al. The spectrum of neurological disease
associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case
series. Beasley DWC, ed. PLoS Negl Trop Dis. 2018;12(2):e0006212.
doi:10.1371/journal.pntd.0006212.
163. Meda N, Salinas S, Kagoné T, Simonin Y, Van de Perre P. Zika virus epidemic: Africa
should not be neglected. Lancet. 2016;388(10042):337-338. doi:10.1016/S01406736(16)31103-5.
164. Olusanya BO. Full-term newborns with congenital microcephaly and macrocephaly in
Southwest Nigeria. Int Health. 2012;4(2):128-134. doi:10.1016/J.INHE.2011.12.006.
165. Tang H, Hammack C, Ogden SC, et al. Zika virus infects human cortical neural
progenitors and attenuates their growth. Cell Stem Cell. 2016;18(5):587-590.
doi:10.1016/j.stem.2016.02.016.
166. Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human
neurospheres and brain organoids. Science. 2016;352(6287):816-818.
doi:10.1126/science.aaf6116.
167. Li H, Saucedo-Cuevas L, Regla-Nava JA, et al. Zika Virus Infects Neural Progenitors in
the Adult Mouse Brain and Alters Proliferation. Cell Stem Cell. 2016;19(5):593-598.
doi:10.1016/j.stem.2016.08.005.
31

168. van den Pol AN, Mao G, Yang Y, Ornaghi S, Davis JN. Zika Virus Targeting in the
Developing Brain. J Neurosci. 2017;37(8):2161-2175. doi:10.1523/JNEUROSCI.312416.2017.
169. Huang W-C, Abraham R, Shim B-S, Choe H, Page DT. Zika virus infection during the
period of maximal brain growth causes microcephaly and corticospinal neuron apoptosis
in wild type mice. Sci Rep. 2016;6(1):34793. doi:10.1038/srep34793.
170. Adams Waldorf KM, Nelson BR, Stencel-Baerenwald JE, et al. Congenital Zika virus
infection as a silent pathology with loss of neurogenic output in the fetal brain. Nat Med.
2018;24(3):368-374. doi:10.1038/nm.4485.
171. Lazear HM, Govero J, Smith AM, et al. A Mouse Model of Zika Virus Pathogenesis. Cell
Host Microbe. 2016;19(5):720-730. doi:10.1016/j.chom.2016.03.010.
172. Kumar A, Hou S, Airo AM, et al. Zika virus inhibits type-I interferon production and
downstream signaling. EMBO Rep. 2016;17(12):1766-1775.
doi:10.15252/embr.201642627.
173. Grant A, Ponia SS, Tripathi S, et al. Zika Virus Targets Human STAT2 to Inhibit Type I
Interferon Signaling. Cell Host Microbe. 2016;19(6):882-890.
doi:10.1016/J.CHOM.2016.05.009.
174. Tripathi S, Balasubramaniam VRMT, Brown JA, et al. A novel Zika virus mouse model
reveals strain specific differences in virus pathogenesis and host inflammatory immune
responses. Pierson TC, ed. PLOS Pathog. 2017;13(3):e1006258.
doi:10.1371/journal.ppat.1006258.

32

Chapter 2: Astrocytes decrease adult
neurogenesis during memory dysfunction via
Il-1
This chapter is adapted from a manuscript published in Nature Immunology:
Garber C, Vasek MJ, Vollmer LL, Sun T, Jiang X, Klein RS. Astrocytes decrease adult
neurogenesis during virus-induced memory dysfunction via IL-1. Nat Immunol.
2018;19(2):151-161. doi:10.1038/s41590-017-0021-y.
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2.1 Abstract
Memory impairment following West Nile virus neuroinvasive disease (WNND) is associated
with loss of hippocampal synapses with lack of recovery. Adult neurogenesis and synaptogenesis
are fundamental features of hippocampal repair, suggesting viruses impact these processes. Here,
using an established model of WNND-induced cognitive dysfunction, transcriptional profiling
revealed alterations in gene expression that limit adult neurogenesis, including interleukin (IL)-1.
WNND-recovered animals exhibit decreased neuroblasts and increased astrogenesis, without
recovery of hippocampal neurogenesis at thirty days. Analysis of cytokine production in ex vivo
isolated microglia and astrocytes revealed the latter to be the predominant source of IL-1. IL1R1-deficient, WNND-recovered mice exhibit normal neurogenesis, recovery of presynaptic
termini, and resistance to spatial learning defects, the latter of which likewise occurred after
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treatment with IL-1R1 antagonist. Thus, preferential generation of proinflammatory astrocytes
impairs neuronal progenitor cell homeostasis via expression of IL-1, which may underlie longterm cognitive consequences of WNND, but provides a therapeutic target.

2.2 Introduction
Members of the Flavivirus genus, which include West Nile (WNV), Japanese encephalitis (JEV),
and Zika (ZIKV) viruses, are the most important arthropod-borne viruses causing encephalitis in
humans1. Acutely, patients suffering from WNV neuroinvasive disease (WNND) can experience
confusion, fatigue, loss of motor control, memory loss, coma, and a mortality rate of 5-10%1. WNV
is a (+)-sense single-stranded RNA virus that targets fully differentiated neurons, but may be
cleared by immune-mediated processes, even after infection of the central nervous system (CNS)2.
However, approximately half of survivors experience debilitating, long-term cognitive sequelae,
including defects in verbal and visuospatial learning, for months to years beyond the acute
infectious event3,4. Animal studies have identified multiple cytokines that play critical roles in cellmediated antiviral immunity, including tumor necrosis factor (TNF)5, type I, II and III interferons
(IFNs)6-9, and interleukin (IL)-110,11, which improve survival. Prior studies have determined that
human and murine neurons are the target of WNV in vivo12-14. Importantly, studies in which critical
cytokines have been deleted via genetic approaches have not led to expanded tropism of WNV to
nonneuronal cells within the CNS10,15. While neuronal death is associated with high mortality in
human and murine cases of WNV encephalitis16, survivors may exhibit limited neuronal loss14,17,
suggesting inflammatory processes triggered acutely contribute to long-term memory dysfunction.
That many patients recovering from WNND experience memory impairments for months to years
beyond viral clearance indeed suggests a chronic condition with either sustained damage or limited
repair.
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In a murine model of recovery from WNND, in which intracranial inoculation of a mutant
WNV (WNV-NS5-E218A) leads to high survival rates with visuospatial learning defects,
hippocampi exhibit up-regulation of genes involved in microglial-mediated synaptic remodeling,
including drivers of phagocytosis and the classical complement pathway, and decreased expression
of synaptic scaffolding proteins and glutamate receptors14. Complement-mediated synapse
elimination has been reported to occur in numerous neuroinflammatory diseases, including
multiple sclerosis18, Alzheimer’s disease19, and schizophrenia20, suggesting this may be a general
mechanism underlying inflammation-associated disruption of neural circuitry. The hippocampus,
essential for spatial and contextual memory formation, receives input from the entorhinal cortex,
which relays through the dentate gyrus, CA3, and CA121. WNV-NS5-E218A-recovered mice with
poor spatial learning show persistence of phagocytic microglia engulfing presynaptic terminals
within the hippocampal CA3 acutely, and during recovery14. While this provides molecular
explanations for poor spatial learning in WNV-recovered animals, it does not explain why other
hippocampal correlates of learning, such as adult neurogenesis, are not able to restore spatial
learning.
Adult neurogenesis occurs within the hippocampal dentate gyrus (DG) and the
subventricular zone (SVZ)22. Within the DG, adult neural stem cells (NSCs) give rise to astrocytes
and intermediate neuronal progenitors, the latter of which proliferate and differentiate into
neuroblasts that mature into granule cell neurons and integrate into the hippocampal circuit over
the course of a few weeks23. This process is regulated by intrinsic and extrinsic factors, including
local signaling molecules, exercise, aging and inflammation24. A variety of endogenous factors
play critical roles in the generation and integration of newly generated neurons in the adult
hippocampus. These include morphogens, such as neurogenic locus notch homolog (Notch)
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proteins, sonic hedgehog (Shh), wingless integrated signals (Wnts), and bone morphogenic
proteins (BMPs), and neurotrophic factors, such as brain-derived neurotrophic factor (BDNF),
ciliary neurotrophic factor (CNTF), insulin-like growth factor-1 (IGF-1), and vascular
endothelium growth factor (VEGF)25. Recently, proinflammatory pathways, including those
triggered by systemic accumulations of TNF, interleukin (IL)-1b, and IL-6, and microglial
activation have been implicated in the regulation of neural correlates of memory including adult
neurogenesis, synaptic plasticity and modulation of long-term potentiation14,26-29.
IL-1, in particular, has gained attention for its impact on cognitive function in the context
of neuroinflammation. IL-1 signaling is mediated by a family of proteins comprised of IL-1a, IL1b, and IL-1 receptor antagonist (IL-1ra) primarily through type I IL-1 receptor (IL-1R1). IL-1b
is generated via proteolytic cleavage of pro-IL-1b by Caspase 1 during inflammasome activation30.
IL-1 is highly expressed in vivo by infiltrating myeloid cells during WNV encephalitis, where it
critically regulates antiviral effector T cell responses10,11. While IL-1 is a key player in
orchestrating CNS immune responses, including onset of fever27, it also plays a role in spatial
learning and memory-related behavior28. Indeed, injection of IL-1b into the brain impairs spatial
learning, contextual fear memory, and adult neurogenesis29–31. Although several studies have
investigated impacts of IL-1 on hippocampal-based learning and behavior in neurologic diseases3135

, none have done so in a setting of IL-1 induction during CNS viral infection.
Here, using an established model of post-infectious cognitive dysfunction from WNND

in which animals display defects in spatial learning, we investigated the regulation of
neurogenesis during repair and recovery. We identified a novel feed forward mechanism in
which IL-1 contributes to spatial learning defects via derailment of hippocampal neurogenesis to
generate proinflammatory astrocytes, which exhibit a previously unidentified role in IL-136

mediated cognitive dysfunction, and that this pathway may be successfully targeted for the
prevention of learning defects during recovery from viral encephalitis.

2.3 Results
WNND-recovered mice exhibit genetic signatures of derailed neurogenesis
Our previous microarray study of hippocampal gene expression in WNV-NS5-E218A-recovered
mice identified several significantly altered pathways in mice with impaired spatial memory
including axon guidance, Wnt signaling, and p53 signaling14, which point to potential effects on
adult neurogenesis. To further examine these pathways, we grouped the genes altered between
Mock and WNV-NS5-E218A-recovered animals into those that promote or inhibit neurogenesis,
here shown as gene expression heatmaps (Fig. 2.1a, b). Expression of genes associated with
inflammation and/or prohibition of neurogenesis (Casp1, Il1a, Tnf, Tnfrsf1a) was higher in WNVNS5-E218A-recovered (Fig. 2.1a) compared with mock-infected mice, which exhibited higher
expression of genes that promote proliferation and differentiation of neuroblasts (Epha5, Wnt2,
Nrg3) and axon guidance (Robo2, Sema3) (Fig. 2.1b). Markers for recently identified subgroups
of reactive astrocytes36 deemed A2 and A1, the latter of which are proposed to be induced by
activated microglia and lose the ability to promote neuronal survival, outgrowth, were also
significantly elevated (Fig. 2.1c, d). Alterations in genes that impact neurogenesis after infection
with WNV-NS5-E218A and markers of reactive astrocytes, including additional panreactive
astrocyte markers36 were validated in an independent set of hippocampal samples by qPCR (Fig.
2.1e-h). These data suggest that WNND might limit adult neurogenesis in favor of astrogenesis.

WNND induces acute loss of adult neurogenesis in the hippocampus
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Given that genetic signatures in the hippocampi of WNV-recovered mice are consistent with
pathways that negatively impact adult neurogenesis, we evaluated the generation of new neurons
during WNV encephalitis. We administered BrdU during the peak of WNV encephalitis for a
period of 4 days (days 3-7), allowed mice to recover for 45 days and then evaluated numbers of
newly generated neurons (Fig. 2.2a-d). WNV-recovered mice exhibited fewer BrdU-labeled
neurons within the DG granule cell layer than mock-infected controls (Fig. 2.2a, c, d). To
determine whether reduction in newly generated neurons in WNV-recovered mice is due to
alteration in the rate of neuronal progenitor cell proliferation, mock-infected versus WNV-NY99infected or WNV-NS5-E218A-infected mice were administered BrdU during the peak of
encephalitis, followed by either immunohistochemical (Fig. 2.3a, b) or flow cytometric (Fig. 2.8)
evaluation of neuronal progenitors, which express doublecortin (DCX+), in the SVZ or
hippocampi, as described previously37. Infections with wild-type WNV (NY-99) via either the
peripheral footpad or intracranial route, or attenuated WNV-NS5-E218A all led to fewer BrdUlabeled neuroblasts at 6-8 days post-infection (Fig. 2.3c). This reduction in generation of
neuroblasts was assessed over the course of recovery from WNND, at days 6, 15, and 30 postinfection (d.p.i.) as compared to age-matched mock-infected controls. This analysis revealed that
significant deficits persist until day 30 in the hippocampus, with a trend towards recovery observed
in the SVZ (Fig. 2.3d). Taken together, these data indicate that hippocampal neuronal repair is
defective after WNND.

WNV does not target NSCs or neuronal progenitors
One possible explanation of fewer new neurons after the recovery period of WNV encephalitis is
that neuroblasts are dying before reaching maturity. In agreement with previous studies, we
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confirmed that neural stem cells and intermediate neuronal progenitors were not permissive to
WNV infection36, and observed that less than 1% of DCX+ neuroblasts were infected in vivo in
both the SVZ and DG (Fig. 2.9a). Furthermore, rates of neuroblast apoptosis during acute WNND
were equivalent to mock-infected controls (data not shown). The few infected neuroblasts that
were observed within the DG were located within the granule cell layer, suggesting that these may
be late-stage DCX+ cells during their transition into immature neurons. Late-stage neuroblasts
exhibit many of the same properties as neurons including, receptors, filament proteins, and cellular
processes (e.g. axon and dendrite formation), thus potentially explaining the ability of WNV to
infect them. Alterations in the proliferation rates of neural progenitors could result in changes to
the overall pool of stem cells over time. Using mice expressing GFP under the Nestin promoter,
we counted the numbers of Nestin and GFAP-double positive neural stem cells remaining within
the hippocampal DG at 45 days post-infection, but found no differences in the numbers of these
cells present in mock and WNV-NS5-E218A recovered mice (Fig. 2.9b). Thus, WNV does not
target or alter the numbers of NSCs, nor does it infection neuroblasts.

Astrocytes are the primary source of IL-1β in the recovering CNS
To further investigate the potential for an alteration in cell fate of early stage progenitors, we
determined whether fewer neuronal progenitors were produced in favor of more glial progenitors
within the hippocampus of WNV-infected mice. To test this, mock- versus WNV-NY- or WNVNS5-E218A-infected mice were administered BrdU during the peak of encephalitis followed by
flow cytometric evaluation of hippocampal neuronal progenitors and astrocytes 48 hours later (Fig.
2.4a, b). Infections with either wild type WNV (NY-99) or WNV-NS5-E218A led to more BrdUlabeled GFAP-expressing astrocytes in the hippocampus at 7 days post infection than mock39

infected controls (Fig. 2.4b). Although GFAP expression varies among astrocyte subpopulations,
recent work has demonstrated that GFAP is the most highly expressed transcript and protein in
astrocytes isolated from the hippocampus38. Next, we determined whether an increase in astrocyte
genesis during acute infection significantly contributes to alterations in the CNS immune profile
after viral clearance. Analysis of ex vivo-isolated astrocytes at 25 d.p.i. demonstrated an increase
in markers of A1, but not A2, reactive astrocyte markers, (Fig. 2.4c, c′). Thus, the slight increases
in neuroprotective markers previously detected in whole hippocampal samples at the same time
point (Fig. 2.1c-e) are likely contributed by other cell types. Analysis of panreactive markers36
also detected increased expression of GFAP (Fig. 2.4c′). Identification of cellular sources of antineurogenic and proinflammatory cytokines in the CNS via transcriptional analysis of ex vivoisolated astrocytes and microglia at 25 d.p.i. revealed astrocytes as the primary source of IL-1b,
Caspase-1, and TNF (Fig. 2.4d). The purity of those cellular sources was confirmed by
transcriptional analysis of cell type-specific markers, as previously reported39. Isolated astrocytes
demonstrated significant enrichment of the astrocyte Gfap gene expression while isolated
microglia show significant enrichment of microglial Cx3cr1 and Trem2 expression. Both ASCA2 positive astrocytes and CD11b positive microglia had negligible expression of the neuronal gene
Rbfox3 (Fig. 2.10). Kinetic analysis of Il1b expression within hippocampi of WNV-NS5-E218Ainfected mice showed persistent elevation of this anti-neurogenic cytokine at 25 d.p.i. (Fig. 2.4e).
Immunohistochemical analysis of mock- and WNV-NS5-E218A-infected tissue at 25 d.p.i. (Fig.
2.4f) confirmed increases in numbers of activated, GFAP+ astrocytes (Fig. 2.4g) that are the
primary cellular source of IL-1b protein expression in the recovering hippocampus (Fig. 2.4h, i).
Taken altogether, these data indicate that WNND promotes the generation of A1 reactive
astrocytes that express anti-neurogenic cytokines.
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Il1r1-/- mice resist alterations in cell fate of early progenitors
To determine whether WNV-mediated reduction in neuroblast proliferation requires IL-1R1
signaling, mock- and WNV-NS5-E218A-infected Il1r1-/- mice were administered BrdU during the
peak of encephalitis, followed by flow cytometric evaluation of hippocampal neuronal progenitors.
In contrast to the reduction in neuroblast proliferation observed in neurogenic zones of wild type
animals, Il1r1-/- mice exhibited normal neurogenesis in both the hippocampus (Fig. 2.5a) and SVZ
(Fig. 2.5b). In addition, Il1r1-/- mice did not undergo the substantial increase in proliferating
astrocytes observed in wild-type animals (Fig. 2.5c). Immunohistochemical identification of
Ki67+ proliferating neural progenitor cells in conjunction with Mash1, which identifies early
neural progenitor cells with neurogenic potential40, within the DG revealed acute WNV-mediated
decreases in wild-type animals, but not in animals deficient in IL-1R1 or Caspase 1 (Casp1-/-),
which cleaves pro-IL-1b to produce mature IL-1b (Fig. 2.5d). Acute viral loads did not differ
between wild-type and Il1r1-/- animals at 6 d.p.i. in various brain regions (Fig. 2.11a-c), and there
was no difference in persistent viral RNA at 25 d.p.i. in the hippocampus (Fig. 2.11d), confirming
that virologic control of WNV-NS5-E218A was intact in Il1r1-/- animals. In addition, flow
cytometric analysis of cells isolated from the hippocampus demonstrated similar numbers of
various subpopulations of resident and infiltrating CD45+ cells in WNV-NS5-E218A infected
wildtype and Il1r1-/- animals (Fig. 2.11e-l). These data support the notion that IL-1R1 signaling
underlies derailment of neurogenesis during WNND.

Il1r1-/- mice exhibit synapse recovery and normal spatial learning
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Given that Il1r1-/- mice are protected from derailed neurogenesis following WNV infection, we
hypothesized that IL-1R1-deficient animals would exhibit improved synapse recovery following
infection with WNV-NS5-E218A. Both WNV-NS5-E218A-infected wild-type and Il1r1-/- mice
exhibit acute loss of presynaptic terminals at 7 d.p.i. (Fig. 2.5e), and wild-type animals continued
to show decreased numbers of presynaptic terminals at 25 d.p.i. In contrast, Il1r1-/- animals
displayed recovery of synapses at this time point (Fig. 2.5f). Given that adult neurogenesis and
synaptic plasticity are critical for spatial learning, we allowed WNV-NS5-E218A-infected, Il1r1/-

mice to recover for a month beyond viral clearance (46 d.p.i.) and tested their ability to spatially

locate and remember the location of a target hole in a Barnes maze over the course of 10 trials held
twice daily for 5 days (Fig. 2.6a). While WNV-recovered, wild-type mice display significant
deficits in spatial learning14 (Fig. 2.6b), the performance of WNV-recovered Il1r1-/- mice was
indistinguishable from mock-infected animals (Fig 2.6c). Area under the curve (AUC) analysis for
each animal, which allows a comprehensive view of how individuals within the group performed
across all 5 days of testing on the Barnes Maze, demonstrated that wild-type animals recovering
from WNND had more severe memory impairments than mock-infected wild-type controls and
WNND recovered Il1r1-/- animals (Fig 2.6d). To assess differences in exploratory behavior that
may affect performance on the Barnes Maze spatial learning task, we performed Open Field testing
(OFT) at 45 d.p.i., 1 day prior to the Barnes Maze (Fig. 2.6a). While the number of lines crossed
during OFT were similar for mock- and WNV-infected mice of both genotypes, mock-infected
Il1r1-/- animals crossed fewer lines than mock-infected wild-type controls (Fig. 2.6e). No
differences in the number of center crosses were observed between all groups (Fig. 2.6f). These
studies demonstrate a critical role for IL-1R1 in limiting synapse and cognitive recovery.

42

IL-1R antagonism prevents WNV-induced spatial learning deficits
In order to explore the potential for therapeutic intervention, we opted to test cognitive recovery
in wild-type animals treated during acute infection with either vehicle or the IL-1R antagonist,
Anakinra. As synapse elimination14 and loss of neurogenesis occurs during acute infection, which
is also when IL-1 expression was highest, we began treatment at 10 d.p.i., a time point during viral
clearance14 when the blood brain barrier was still permeable (Fig. 2.12). Mock- or WNV-NS5E218A-infected animals received 5 daily intra-peritoneal doses of vehicle or Anakinra, and then
recovered for 30 days prior to Barnes Maze testing at 46 d.p.i. (Fig. 2.7a). As expected, vehicle
treated WNND recovered animals were significantly impaired in their ability to identify the
location of the target hole during Barnes Maze testing (Fig. 2.7b). In contrast, animals treated with
Anakinra were protected from WNV-induced spatial learning impairment (Fig. 2.7c). AUC
analysis confirmed that WNND-recovered animals treated with Anakinra had improved
performance on the Barnes Maze compared with vehicle treated animals (Fig. 2.7d). Finally, OFT
at 45 d.p.i. demonstrated that there were no differences between any of the groups in exploratory
behavior, locomotion, or number of center crosses (Fig. 2.7f). These studies identify a potential
therapeutic target for the prevention of spatial learning defects that occur during recovery from
WNND.

2.4 Discussion
The original designation of cytokines as immune modulators has expanded to include a variety of
functions in nonlymphoid tissues, especially the CNS, where they play critical roles in
neurodevelopment. Regulation of signaling by the gp130 family of cytokines through Janus
Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathways maintains the
pool of neural stem and progenitor cells (NPCs), promoting neurogenesis of the latter41. During
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development, IL-1R1 is also expressed on proliferating NPCs and IL-1b exerts an antiproliferative, anti-neurogenic and pro-gliogenic effect on embryonic hippocampal NPCs in
vitro42,43. Studies of viral encephalitis have demonstrated critical roles for innate cytokines
expressed by infiltrating immune cells in T cell-mediated clearance of pathogen. However, their
impact on CNS recovery and repair after viral clearance via actions on NPCs has not been
elucidated. Our findings suggest that during the acute phase of viral infection, myeloid cell-derived
IL-1 (ref.10) alters the proliferation and differentiation fates of neural progenitor cells, leading to a
shift from neurogenesis to astrogenesis. Proinflammatory astrocytes then become the predominant
source of the cytokine, which continues to inhibit neurogenesis, after myeloid cells retreat from
the CNS14. Accordingly, mice deficient in IL-1R signaling are resistant to both derailment of
neurogenesis as well as spatial memory impairments, which are observed in wild-type WNVrecovered mice. Because loss of neurogenesis is detected early in the course of infection,
administration of IL-1R antagonist at 10 d.p.i., a time-point when the BBB is still permeable, was
able to reverse the effects of IL-1 and improve spatial learning. Our data indicate that the
combinatorial effect of synapse loss14 and reduced neurogenesis can negatively impact
hippocampal spatial learning and memory long beyond the initial episode of infection via a shift
in sources of cytokines to neural cells.
Other neurotropic flaviviruses, including Japanese Encephalitis and Zika Virus, have been
shown to directly infect neural progenitors, causing apoptosis of progenitors and progeny44,45. In
agreement with previous studies46, we found very few neural progenitor cells infected with WNV.
However, transcriptional profiling detected altered expression of genes implicated in hippocampal
neurogenesis during WNND recovery. These included increased expression of genes that encode
CDKN1a, CDCA4, and CCND1, cell cycle progression inhibitors, and decreased expression of
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genes that encode Epha5 and Sema6B, which regulate hippocampal axon pathfinding during neural
development47,48, were detected during WNND recovery. We also detected alterations to the Wnt
signaling pathway, which can impact neural progenitor cell proliferation and motility, but also
regulates synapse formation49 and plasticity50, potentially contributing to the failure of mice to
recover from both neurogenesis derailment as well as WNV-mediated synapse loss14. The genetic
signatures present during WNV recovery describes an environment which both impedes neural
progenitor cell proliferation and the ability of immature and mature neurons to form new synapses.
While previous studies have detected IL-1R1 within the hippocampus51, recent research
highlighting astrocyte heterogeneity has not identified these cells as a first target of IL-152. In
contrast, numerous studies have implicated neural progenitor cells as a significant target of IL-1.
IL-1a and IL-1b have both been shown to induce neural stem and progenitor cells to favor the
astrocyte rather than neuronal lineage in vitro42. TNF, which is highly expressed in WNV-infected
brains5 in an IL-1R-dependent manner10, has been shown in other contexts to direct neuronal
progenitors towards an astrocyte fate via downstream STAT3 induction53, suggesting that these
may be part of the same anti-neurogenic pathway. In vivo studies using overexpression and stress
models have shown that IL-1b decreases neurogenesis43,54,55, and influences synaptic plasticity56,57,
processes that are vital for the development and retention of spatial memory. We found that
abundance of IL-1b during acute infection altered lineage fate of neural stem cells within
neurogenic zones of the CNS favoring astrocyte genesis. This led to a feed-forward cycle of
inflammation, as astrocytes became the primary source of IL-1β in the recovering hippocampus.
IL-1R1-deficient mice were protected from decreased neurogenesis following WNV infection, and
retained the ability to learn a spatial memory task. Importantly, we demonstrated that the effect
was specific to inflammasome-activated IL-1b by confirming that Casp1-/- animals were also
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protected from decreased neurogenesis. In studies using cultured NPCs, IL-1b and TNF are both
capable of altering lineage-fate to favor greater numbers of astrocytes and both of these pathways
are dependent on downstream STAT3 activation58. While we focused on the role and necessity of
IL-1R signaling, TNF, which was also upregulated by astrocytes at 25 d.p.i., may also contribute
to the observed lineage fate-altering phenotype.
While multiple studies have described effects of cytokines released from astrocytes59 and
microglia60 on memory and hippocampal neurogenesis, the precise contributions of each cell type
in vivo remain ill-defined. In the current study, we found that astrocytes within WNV-recovered
CNS express increased expression of Il1b, Casp1 and Tnf, whereas microglia increased expression
of Ccl2. Astrocytes display a regional heterogeneity38,52, which can also reflect differences in
homeostatic function, such as synaptogenesis52, and response to infection, where cerebellar
astrocytes are poised to quickly mount antiviral programs61. In addition to developmentally
determined sub-populations62,63, astrocytes display a remarkable plasticity and molecular identity
determined in part by neuronal cues64. In response to different types of injury, reactive astrocytes
can develop a recently described polarized phenotype termed A1 (infection induced, proinflammatory astrocytes) or A2 (ischemia induced, promoting tissue repair) that are distinguished
by distinct genetic signatures36. In this study, A1 astrocytes were induced in vivo by
lipopolysaccharide injection and the combination of IL-1a, TNF, and C1q was observed to promote
A1 polarization in vitro. Our model of viral infection also exhibits elevated production of IL-1,
TNF, and C1q14. Consistent with this, we also observed the in vivo development and persistence
of astrocytes with panreactive and A1 markers. As proinflammatory astrocytes lose the ability to
phagocytose due to a decrease in mRNA expression of the phagocytic receptors Mertk and Megf10,
and fail to support synaptogenesis in vitro due to decreases in expression of Gpc6 and Sparcl1,
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factors that normally promote excitatory synapse formation36. Thus, the lack of recovery of
synapses in our model could be explained by the generation of this subset of reactive astrocytes.
Alternatively, lack of recovery could also be due to the loss of a specific astrocyte population that
normally promotes synaptogenesis52. Although expansion of a synapse-promoting astrocyte
population leads to seizures in the context of a reactive glioma52, this population may be crucial
for CNS repair in the setting of the diverse array of diseases recently associated with loss of
synapses in addition to WNV encephalitis, including Alzheimer’s disease19, schizophrenia20, and
lupus65. Further studies are needed to more fully understand how homeostatic astrocyte
populations respond to CNS injury, and whether this correlates with regional or functional identity.
The discovery that newly derived, reactive astrocytes of a recently identified proinflammatory
subset36 are responsible for persistently decreased adult neurogenesis during WNV recovery also
suggests cell-type specific studies will be required to elucidate these pathways in disease models.
There is a growing body of experimental evidence demonstrating the importance of
homeostatic neuroimmune interactions for normal cognitive function (recently reviewed by66,67).
However, the effects of immune mediators on brain function depend on their levels and
locations; this phenomenon was classically demonstrated as a U-shaped curve relating the effect
of IL-1 signaling on cognitive function in which either overexpression or complete blockade of
IL-1 signaling both negatively impacted spatial learning68. Thus, in the context of
neuroinflammation, increased expression of immune molecules may similarly lead to altered
cognitive performance. Of note, we observed a trend towards recovery of neurogenesis in the
SVZ that was absent in the hippocampus, an effect that has been reported previously in response
to ionizing radiation69, suggesting a differential responses to injury in these neurogenic niches.
Interestingly, in a study of hypoxia driven neuroinflammation, hippocampal neurogenesis
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decreased, while SVZ neurogenesis increased, an effect that was linked to IL-6 signaling70.
Further work addressing the mechanism underlying differential responsiveness to cytokine
signaling in neurogenic niches could shed light on basic aspects of neural precursor cell biology.

2.5 Methods
Animals
5-8 week-old male mice were used at the outset of all experiments. C57BL/6J mice were obtained
from Jackson Laboratories. Il1r1–/– mice (> 10 generations backcrossed to C57BL/6) were
obtained from Jackson Laboratories. Nestin-GFP mice (> 10 generations backcrossed to C57BL/6)
were obtained from G. Enikolopov (Cold Spring Harbor Laboratories). All experimental protocols
were performed in compliance with the Washington University School of Medicine Animal Safety
Committee (protocol# 20140122).

Mouse models of WNV infection
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000 (Ebel et
al., 2001) and passaged once in C6/36 Aedes albopictus cells to generate an insect cell–derived
stock. 100 plaque-forming units (pfu) of WNV-NY99 were delivered in 50 ul to the footpad of
anaesthetized mice.

Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyltransferase gene, was obtained from M. Diamond (Washington University) and passaged in Vero
cells as described previously41. Deeply anaesthetized mice were administered 104 pfu of WNVNS5-E218A or 10 pfu of WNV-NY99 in 10 ul of 0.5% FBS in HBSS into the brain’s third ventricle
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via a guided 29-gauge needle. “Mock” infected animals were deeply anesthetized and administered
10 ul of 0.5% FBS in HBSS into the brain’s third ventricle via a guided 29-gauge needle.

Stock titers of all viruses were determined by using BHK21 cells for viral plaque assay as
previously described42.

Microarray analysis.
Further analysis was performed on previously published hippocampal microarray gene expression
data14 (Gene Expression Omnibus #GSE72139) from Mock-infected and WNV-NS5-E218A
animals at 25 days post infection. Expression data from selected genes (P < 0.05 or P < 0.1 for
italicized genes, Two-tailed Students t-test) were converted to Z-scores for each individual gene
and animal and are displayed as colorimetric heatmaps.

In vivo bromodeoxyuridine (BrdU) labeling.
BrdU (Sigma Aldrich) in sterile PBS was injected intraperitoneally (IP) for all experiments. For
acute Immunohistochemical studies (harvests day 7-8 post-infection) mice were given 150 mg/kg
of BrdU at 48 h prior to tissue harvest. For flow cytometric analyses, mice were given 100 mg/kg
of BrdU at 48 h and again at 24 h prior to tissue harvest. For neuronal BrdU labeling, mice were
given 75 mg/kg every 12 h beginning at 3 days post-infection and ending at 7 days post-infection
for a total of 7 doses.

Antibodies
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WNV (1:100 described previously8), NeuN (1:100, Cell Signaling, Cat 12943S, Clone D3S3I),
BrdU (1:200, Abcam, Cat ab1893, polyclonal), CD45 (Biolegend, Cat 103114, Clone 30-F11),
Doublecortin (1:150, Cell Signaling, Cat 4604S, polyclonal), GFAP (1:50 for flow cytometry; 1:
200 for IHC, BD, Cat 561483, Clone 1B4), IL-1b (R&D, Cat AF-401, polyclonal), Mash1 (BD,
Cat 556604, Clone 24B72D11.1), Ki67 (Abcam, Cat AB15580, polyclonal), Synaptophysin
(1:250, Synaptic Systems, Cat 101004, polyclonal). Secondary antibodies conjugated to Alexa488, Alexa-555, or Alexa-647 (Invitrogen) were used at a1:400 dilution.

Immunohistochemistry
Following perfusion with ice-cold PBS and 4% paraformaldehyde (PFA), brains were immersionfixed overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72 h,
then frozen in OCT (Fisher). 9 um-thick fixed-frozen coronal brain sections were washed with
PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and nonspecific Ab was blocked
with 5-10% normal goat serum (Santa Cruz Biotechnology) for 1 h at 23°C. Mouse on Mouse kit
(MOM basic kit, Vector) was used per manufacturers protocol when detecting synaptophysin
(mouse, DAKO) to reduce endogenous mouse Ab staining. After block, slides were exposed to
primary Ab or isotype matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and
incubated with secondary Abs for 1 h at 23°C. Nuclei were counterstained with DAPI (Invitrogen)
and coverslips were applied with vectashield (Vector). Immunofluorescence was analyzed using a
Zeiss LSM 510 laser-scanning confocal microscope and accompanying software (Zeiss). For each
animal, 6-8 images were taken from 2-3 different coronal sections spaced at least 50 um apart.
Positive immunofluorescent signals were quantified using the public domain NIH Image analysis
software, ImageJ.
50

Flow cytometry
Cells were isolated from brains of WT mice at day 6, 15, or 30 days post-infection and stained
with fluorescently conjugated antibodies to CD45, BrdU, and Doublecortin as previously
described37. Briefly, animals were deeply anesthetized with a ketamine/xylazine mixture and
perfused intracardially with ice cold dPBS (Gibco). Brains were aseptically removed, minced and
enzymatic digested in HBSS (Gibco) containing collagenase D (Sigma, 50mg/ml), TLCK trypsin
inhibitor (Sigma, 100 ug/ml), DNase I (Sigma, 100U/ul), HEPES ph 7.2 (Gibco, 1M), for 1hr at
23°C while shaking. The tissue was pushed through a 70 um strainer and spun down at 500g for
10min. The cell pellet was resuspended in a 37% percoll solution and spun at 1200g for 30min to
remove myelin debris. Cells were washed in PBS, then resuspended in FACS buffer. Cells were
blocked with TruStain fcX anti-mouse CD16/32 (Biolegend) for 5 min on ice, followed by
incubation with fluorescently conjugated antibodies for 30 min on ice. Cells were then washed 2
times in PBS, fixed with 4% PFA for 10 min at 23°C and resuspended in FACS buffer. Data
collection was performed with LSR-II (BD Biosciences) and analyzed with Flowjo software.

Ex vivo isolation of microglia and astrocytes with microbeads
Animals were deeply anesthetized with a ketamine/xylazine mixture and perfused intracardially
with ice cold dPBS (Gibco). Brains were aseptically removed, minced and enzymatic digested in
HBSS (Gibco) containing collagenase D (Sigma, 50mg/ml), TLCK trypsin inhibitor (Sigma, 100
ug/ml), DNase I (Sigma, 100 U/ul), HEPES 7.2 (Gibco, 1M), for 1hr at 23°C while shaking. The
tissue was pushed through a 70 um strainer and spun down at 500g for 10min. The cell pellet
was resuspended in a 37% percoll solution and spun at 1200g for 30 min to remove myelin
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debris. Cells were washed in PBS then resuspended in MACS buffer. CD11b+ Microglia and
ACSA-2+ astrocytes were isolated using manual MACS sorting according to the manufacturer’s
instructions (Miltenyi Biotec). Non-specific labeling of CD11b+ microglia was prevented by
incubating the cells with FcR blocking reagent prior to labeling the cells with ACSA-2
antibodies for magnetic isolation. The purified microglia and astrocytes were processed for realtime quantitative RT-PCR as described below.

Real-time quantitative RT-PCR
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse transcriptase
(Applied Biosystems). A single reverse transcription master mix was used to reverse transcribe all
samples in order to minimize differences in reverse transcription efficiency. The following
conditions were used for reverse transcription: 25°C for 10 min, 48°C for 30 min, and 95°C for 5
min. Real-time quantitative RT-PCR was performed as previously described14.

Behavioral Testing
Open field and Barnes Maze testing was performed as previously describe14. Briefly, mice were
tested on the Barnes Maze over the course of 5 consecutive days, receiving two trials per day,
spaced 30 minutes apart. For each trial, the mouse was given 3 minutes to explore the maze and
find the target hole. Mice that did not enter the target hole within 3 minutes were gently guided
into the hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then
was returned to its home cage. The maze was decontaminated with 70% ethanol between each
trial. The numbers of errors (nose pokes over non-target holes) were measured. One day prior to
Barnes Maze testing, mice were tested via open field testing to monitor differences in exploratory
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behavior. Each animal was given 5 minutes to explore an open field arena before returning to its
home cage. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a blinded
experimenter scored the trials.

Anakinra Treatment
Anakinra (Kineret®, Sobi) was diluted in PBS to 10 mg/mL and animals were treated with 100
mg/kg/day of Anakinra or Vehicle (PBS) for 5 consecutive days by intraperitoneal (ip) injection.
Animals were weighed daily to monitor for weight loss or adverse events, none of which were
observed during the course of treatment.

Statistical Analysis
Statistical analyses were performed using Prism 7.0 (GraphPad Software). All data were analyzed
using an unpaired student’s t-test, one-way or two-way ANOVA with Bonferroni post-test to
correct for multiple comparisons as indicated in the corresponding figure legends. A P value of <
0.05 was considered significant.
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2.8 Figures

Fig. 2.1. Gene transcripts that impact neurogenesis and markers of proinflammatory
astrocytes are altered in WNV-recovered mice. (a-d) Heat maps show relative expression by
z-score of altered genes generated by microarray analysis of hippocampal RNA collected at 25
days post infection (d.p.i.) from Mock, and WNV-NS5-E218A infected, recovering mice. All
genes listed in black font show significant fold change (P < 0.05 by two-tailed Student’s t-test)
while those in green are trending toward significance (0.05 < P < 0.1 by two-tailed Student’s tTest). (e-h) Validation of microarray hits by QPCR in an independent sample of hippocampal
RNA collected at 25 d.p.i. from mock and WNV-NS5-E218A infected, recovering mice. *, P <
0.05; ** P < 0.01, *** P < 0.001, by two-tailed Student’s t-test. Each symbol represents an
individual mouse; data are mean ± s.e.m. . Data are pooled from 2 independent experiments with
4-10 mice per condition in each. Panels of gene-expression markers include genes that are pro
and anti-neurogenic (e), A1 & A2 astrocyte markers (f-g) and panreactive astrocyte markers (h).
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Fig 2.2 Fewer new neurons are born within the dentate gyrus during WNV-NS5-E218A
recovery. (a) Representative image of the dentate gyrus of Mock and WNV-NS5-E218A infected
animals at 45 d.p.i., following in vivo BrdU labeling during acute infection. BrdU (red), NeuN
(green), and DAPI (blue). (b) Experimental design. Mice were given BrdU by intraperitoneal
injection every 12 hours for 3.5 days (7 injections) beginning at 4 d.p.i., then animals were
sacrificed at 45 d.p.i. for immunohistochemical analysis. (c, d) Quantification of BrdU+NeuN+
cells per section of dentate gyrus depicted in panel a (c), and normalized to the number of BrdU+
cells. *, P < 0.05 by two-tailed, Student’s t-test. ***, P < 0.001. Each symbol represents an
individual mouse; small horizontal lines indicate the mean (± s.e.m). Data are representative of
one experiment.
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Fig 2.3 Deficits in adult neurogenesis during WNV infection. (a) Experimental design. Mock,
WNV-NY99 or WNV-NS5-E218A mice were given an i.p. BrdU injection (100 mg/kg) at 24
and 48 hours prior to harvest at 6, 15, or 30 d.p.i. (b) Cells were isolated from subventricular
zone (SVZ) or hippocampus (HP) and proliferation rates of neuroblasts (% BrdU incorporation)
was measured by flow cytometry. Representative plots showing BrdU+ cells after gating on
doublecortin+ (DCX) cells (see Supplementary Fig. 1) in mock, WNV-NY-99 and WNV-NS5E218A intracranially infected animals. (c) Quantification of proliferating neuroblasts (%DCX+
cells labeled with BrdU) in the hippocampus and subventricular zone at 6, 15, and 30 d.p.i.
following in vivo BrdU labeling as shown in a. (d) Representative images and quantification of
immunostaining for proliferating neuroblasts in the SVZ and HP following footpad infection
with WNV-NY99. *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed student’s t-test.
Quantification in c and d was normalized to age-matched mock-infected controls to compensate
for age-related alterations in neurogenesis. Each symbol represents an individual mouse; small
horizontal lines indicate the mean (± s.e.m.). Data are pooled from 2 independent experiments
with 3-5 mice per condition per time point (c) or representative of one experiment with 5 mice
(d).
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Fig 2.4. Greater numbers of astrocytes are born within the hippocampus during acute
WNV encephalitis which adopt a proinflammatory phenotype and express IL-1b. (a,b)
Mock, WNV-NY99 and WNV-NS5-E218A infected mice were given an i.p. BrdU injection at
24 and 48 hours prior to harvest at 6 d.p.i. Cells were isolated from dissected hippocampi and
stained for flow cytometry. Quantification of neurogenesis (BrdU+DCX+) and astrogenesis
(BrdU+GFAP+) was normalized to mock. Gene expression analysis of (c) A1, and (c’) A2 and
panreactive astrocyte markers in ex vivo isolated astrocytes from mock and WNV-NS5-E218A
whole brains by qPCR. (d) Gene expression analysis of cytokines in ex vivo isolated microglia
and astrocytes from WNV-NS5-E218A whole brains by qPCR, normalized to mock-infected
samples of the respective cell types. (e) Gene expression of Il1b by qPCR of RNA isolated from
hippocampal tissue collected at 7, 25, and 52 d.p.i. from mock and WNV-NS5-E218A infected
animals. (f-i) Immunostaining for IL-1 in hippocampus of mock and WNV-NS5-E218A
infected animals collected at 25 d.p.i. Representative images are shown in f, percent area of
GFAP in g, percent area of IL-1 in h, and percent area of Il-1b +GFAP+ normalized to total IL1 + area in i. *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed student’s t-test. Each
symbol represents an individual mouse; small horizontal lines or bar height represent the mean
(± s.e.m.). Data are representative of one experiment (a,b,e-i), or pooled from three independent
experiments with at least 3 mice per group (c, c’, d).
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Fig 2.5. IL-1R1-/- mice resist WNV-mediated alterations in neuroblast proliferation and
recover synapses earlier than wildtype controls. (a,b) Mock and WNV-NS5-E218A infected
wild-type (WT) and Il1r1-/- animals were assessed for alterations in neurogenesis at 6 d.p.i.
following in vivo BrdU labeling at 24 and 48 hours prior to harvest. Quantification of BrdU+DCX+
cells by flow cytometry are shown for the hippocampus (HP) in a and the subventricular zone
(SVZ) in b, normalized to age-matched mock infected controls. (c) Mock and WNV-NS5-E218A
infected Il1r1-/- animals were assessed for alterations in astrogenesis at 6 d.p.i. following in vivo
BrdU labeling at 24 and 48 hours prior to harvest. Quantification of BrdU+GFAP+ cells by flow
cytometry are shown for the hippocampus, normalized to age-matched mock infected controls. (d)
Hippocampal neurogenesis in Mock and WNV-NS5-E218A infected WT, Il1r1-/-, and Caspase-1/(Casp1-/-) was analyzed by immunohistochemistry (IHC) at 6 d.p.i. Quantification of the number
of Mash1+Ki67+ cells per mm of dentate gyrus analyzed. (e-f) Immunostaining of synapses in
mock and WNV-NS5-E218A infected WT at Il1r1-/- animals at 7 d.p.i. in e and 25 d.p.i. in f.
Quantification shows percent area of synaptophysin in the CA3 of the hippocampus.
Synaptophysin (red) and DAPI (blue). *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed
student’s t-test. Each symbol represents an individual mouse; height of bar indicates the mean (±
s.e.m.). Data are pooled from 2 independent experiments (a,b) or representative of one experiment
(e-f) with 4-5 mice/group.
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Fig 2.6. Il1r1-/- WNV-NS5-E218A-infected mice are protected from virus-induced spatial
learning deficits on the Barnes Maze behavior task. (a) Experimental design. Mock or WNVNS5-E218A infected wild-type (WT) and Il1r1-/- underwent behavioral testing beginning at 45
d.p.i. Open field testing was performed at 45 d.p.i., followed by 5 consecutive days of Barnes Maze
testing. (b) Barnes maze performance of WT mice, showing average errors per trial of each group
for each day of testing. (c) Barnes maze performance of Il1r1-/- mice. (d) Barnes Maze
performance of mock and WNV-NS5-E218A infected mice, quantified as area under the curve for
each individual animal within each group. (e) Open Field testing showing the number of lines
crossed in 5 minutes of testing for each animal. (f) Open Field testing showing the number of times
an animal crossed the center of the arena in 5 minutes of testing for each animal. For Barnes Maze,
ns = not significant (P > 0.05), *, P < 0.05 by two-way ANOVA for effect of WNV. ns = not
significant (P > 0.05), *, P < 0.05, **, P < 0.005 by one-way ANOVA with Bonferroni’s multiple
comparisons test to compare groups. Each symbol represents an individual mouse; small horizontal
lines or height of bars represents the mean (± s.e.m.). Data are pooled composite experiments with
at least 4 animals per group.
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Fig 2.7. WNV-NS5-E218A-infected mice treated with Anakinra are protected from virusinduced spatial learning deficits on the Barnes Maze behavior task. (a) Experimental design.
Mock or WNV-NS5-E218A infected wild-type (WT) mice were treated with 5 consecutive doses
of 100mg/kg/day of Anakinra or vehicle by intraperitoneal (ip) injection beginning at 10d.p.i.
Animals were allowed to recover for an additional 30 days post treatment, followed by behavior
testing at 45 d.p.i. Open Field testing was performed at 45 d.p.i., followed by 5 consecutive days
of Barnes Maze testing. (b) Barnes maze performance of vehicle treated WT mice, showing
average errors per trial of each group for each day of testing. (c) Barnes maze performance of
Anakinra treated wildtype mice. (d) Barnes Maze performance of mock and WNV-NS5-E218A
infected mice, quantified as area under the curve for each individual animal within each group.
(e) Open Field testing showing the number of lines crossed in 5 minutes of testing for each
animal. (f) Open Field testing showing the number of times an animal crossed the center of the
arena in 5 minutes of testing for each animal. For Barnes Maze, ns = not significant (P > 0.05),
*, P < 0.05 by two-way ANOVA for effect of WNV. ns = not significant (P > 0.05), *, P < 0.05,
**, P < 0.005 by one-way ANOVA with Bonferroni’s multiple comparisons test to compare
groups. Each symbol represents an individual mouse; small horizontal lines or height of bars
represents the mean (± s.e.m.). Data are pooled composites of 3 independent experiments, with at
least 3 animals per group.
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Fig 2.8 Flow cytometry gating strategy
(a) Following isolation and staining with Dapi and antibodies to CD45, Doublecortin, and
BrdU, doublets were excluded, and the CD45-negative population was utilized for further
gates. b Percentage of BrdU+ neuroblasts, through expression of the marker, DCX, was
calculated and example plots shown from Hippocampus (HPC), Hippocampus from an animal
which did not receive BrdU injection (HPC no BrdU), Cortex (CTX), and Subventricular
Zone (SVZ).
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Fig 2.9 WNV permissivity of DCX+ neuroblasts in vivo
a 5 week old mice were infected via the footpad with 100 pfu of wild type WNV(NY99) and
harvested for tissue collection on day 8 post infection. Immunohistochemistry is shown for
West Nile antigen and the neuroblast marker, doublecortin (DCX) within the Dentate gyrus
(DG) and Subventricular Zones (SVZ). Many WNV+ neurons can be seen within the granule
cell layer (GCL) of the DG and the striatum neighboring the SVZ, however only 1 out of 4
animals showed any WNV and DCX-double positive cells (shown by white arrowhead, Left),
resulting in a mean % of infection of less than 1% of total DCX+ cells. Within the DG,
infected DCX+ cells were always located within the GCL—indicating that they are more
mature neuroblasts or immature neurons. bImmunostaining for GFP and GFAP in mock and
WNV-NS5-E218A nestin-GFP reporter animals. Representative images of the dentate gyrus
are shown on the left and quantification of Nestin+ transit amplifying (TA) and
Nestin+GFAP+ neural stem cells (NSC) on the right. Nestin-GFP (green), GFAP (red) and
DAPI (blue). ns = not significant (P > 0.05).
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Fig 2.10 Determination of astrocyte and microglia purity
qRT-PCR analysis of expression of cell type specific astrocyte (GFAP), microglia (Cx3CR1,
Trem2), and neuronal (RBFox3) transcripts in ex vivo isolated astrocytes (ASC2+ cells) and
microglia (CD11b+ cells). *, P < 0.05 using two-way ANOVA followed by Bonferonni post
test.
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Fig 2.11 Lack of IL-1 signaling does not affect viral control of immune cell infiltrates to the
CNS
a-c Plaque assay of CNS tissue from WNV-NS5-E218A infected wildtype (WT)
and Il1r1−/− animals at 6 d.p.i. d qPCR analysis of WNV envelope protein at 25 d.p.i. in
hippocampus from WNV-NS5-E218A WT and Il1r1 −/− mice. e-l Flow cytometric analysis of
stained single cell populations isolated from hippocampus of WT and Il1r1 −/− mice at 6 d.p.i.
ns = not significant (P > 0.05 using two tailed student’s t test).
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Fig 2.12 Blood brain barrier opening peaks at 6 dpi, and closes by 12 dpi
a-c Relative blood brain barrier permeability of the frontal cortex, hippocampus, and
cerebellum at 3, 6, 9, and 12 d.p.i. was assessed by an in vivo sodium fluorescein assay to
determine optimal time for drug administration. d.p.i.: Days Post Infection.
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Chapter 3: T cells promote microgliamediated synaptic elimination and cognitive
dysfunction during recovery from
neuropathogenic flaviviruses
This chapter is adapted from a manuscript published in Nature Neuroscience:
Garber C, Soung A, Vollmer LL, Kanmogne M, Last A, Brown, J, Klein RS. T cells promote
microglia-mediated synaptic elimination and cognitive dysfunction during recovery from
neuropathogenic flaviviruses. Nat Neurosci. 2019;22(8):1276-1288. doi:10.1038/s41593019-0427-y.

C.G., A.S., and R.S.K. designed the experiments. C.G., A.S., L.L.V., M.K., A.L., and J.B.
performed experiments. C.G., A.S., L.L.V., M.K., and R.S.K analyzed the data. R.S.K., C.G.,
and A.S. wrote the paper. All authors read and edited the manuscript.

3.1 Abstract
T cells clear virus from the CNS and dynamically regulate brain functions, including spatial
learning, through cytokine signaling. Here we determined whether hippocampal T cells that
persist after recovery from infection with West Nile virus (WNV) or Zika virus (ZIKV) impact
hippocampal-dependent learning and memory. Using newly established models of viral
encephalitis recovery in adult animals, we show that in mice that have recovered from WNV or
ZIKV infection, T cell-derived interferon-γ (IFN-γ) signaling in microglia underlies spatiallearning defects via virus-target-specific mechanisms. Following recovery from WNV infection,
mice showed presynaptic termini elimination with lack of repair, while for ZIKV, mice showed
extensive neuronal apoptosis with loss of postsynaptic termini. Accordingly, animals deficient in
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CD8+ T cells or IFN-γ signaling in microglia demonstrated protection against synapse
elimination following WNV infection and decreased neuronal apoptosis with synapse recovery
following ZIKV infection. Thus, T cell signaling to microglia drives post-infectious cognitive
sequelae that are associated with emerging neurotropic flaviviruses.

3.2 Introduction
Among the most debilitating consequences of arboviral infections of the CNS is impairment in
cognitive function that occurs despite recovery from acute encephalitis. Mosquito-borne
infections with flaviviruses, in particular and including WNV and Japanese encephalitis virus,
are linked to significant long-term cognitive sequelae, including decreases in psychomotor speed
and in verbal and visuospatial learning, which not only persist but also worsen for years after
recovery from encephalitis1. In addition, the recently emerged and related flavivirus ZIKV may
cause a range of neurological complications in adults, including encephalopathy, and
meningomyelitis or encephalomyelitis, which may be associated with defects in memory and
cognition with unknown long-term outcomes for survivors2. In the adult CNS, WNV targets fully
differentiated neurons3, whereas Japanese encephalitis virus targets immature neurons4 and
ZIKV may additionally target microglia5 and neural progenitors6 depending on the strain. That
recovery from infection with these viruses may all correlate with reduced learning abilities,
despite their differential tropism for neural cell subtypes, suggests that events triggered acutely
may be generalizable for a broader category of memory disorders.
The formation and consolidation of memories occur primarily in the hippocampus and depends
on the integrity of a trisynaptic circuit between the entorhinal cortex, the hippocampal dentate
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gyrus (DG) and the cornu ammonis (CA). In particular, excitatory connections between CA3
pyramidal neurons support the formation of spatial memories in adult rodents7. Accordingly,
memory disorders, including those associated with Alzheimer’s disease (AD), Parkinson’s
disease, and post-viral encephalitis cognitive sequelae, are all associated with disruptions in
circuit integrity via synapse elimination or neuronal loss within the hippocampus8–10. Microglial
function is critical for synaptic plasticity and for maintenance of adult neurogenesis within
neurogenic niches11,12. While mechanisms contributing to hippocampal dysfunction are
incompletely understood, recovery from WNV infection clearly involves alterations in the
homeostatic functions of microglia and astrocytes. This is because reactive changes in these cells
persist for weeks after clearance of the infectious virus, which lead to complement-mediated
synapse elimination within the CA3 region10and interleukin-1 (IL-1)-mediated inhibition of
synaptic repair13.
Activation of microglia and astrocytes in the acutely infected CNS promotes the parenchymal
entry of antiviral T cells, which exert virological control via cytokine-mediated, non-cytolytic
mechanisms. T cell cytokines such as IFN-γ may also influence microglial biology. In brain
tissues of patients with multiple sclerosis, Parkinson’s disease, or AD, infiltrating T cells are
found in proximity to activated microglia14–16, and transition into AD dementia correlates with
increased numbers of microglial majorhisto-compatibility complex II (MHCII)+ cells17. IFN-γ
influences social interactions18, synapse formation19, neurogenesis20, and learning and memory21,
primarily through regulatory mechanisms. Thus, IFN-γ-deficient animals show increased rates of
hippocampal neurogenesis and synapse formation and hyperconnectivity in the pre-frontal
cortex18,19, all of which are partially reversed by an injection of recombinant IFN-γ into the
cerebrospinal fluid. Such effects suggest that IFN-γ dynamically influences circuit plasticity in
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adult animals. Resident memory T (Trm) cells, which reside in non-lymphoid tissues at sites of
prior antigen exposure, produce IFN-γ to coordinate rapid recall responses following rechallenge22. Although there is evidence to indicate that IFN-γ+ T cells may induce microglial
activation, the functional implications of a parenchymal population of T cells that persist in the
CNS after clearance of viral infections remain unknown.
In this study, we demonstrate that antiviral T cells that persist within the hippocampus after
recovery from flaviviral infection are the most proximal trigger of spatial-learning defects. Using
newly established in vivo models of recovery from flaviviral encephalitis caused by either a
mutant WNV (WNV-NS5-E218A) or ZIKV (Zika-Dakar virus) infection, we determined that
CD8+ T cell-derived IFN-γ is required for microglial activation and impaired spatial learning in
the post-infectious CNS. We show that WNV and ZIKV differentially target forebrain regions
within adult mice, especially with regard to the hippocampus, which exhibited dramatic
differences in neuropathology. However, while both flaviviruses led to the persistence of IFNγ+CD8+ T cells and microglial activation in the hippocampus following recovery, WNV infection
was associated with the elimination of presynaptic termini, while ZIKV promoted the loss of
neuronal nuclei and postsynaptic termini. Subpopulations of these T cells expressed CD 103, a
marker associated with the formation of brain Trm cells, which suggests that the newly formed
Trm cells might contribute to these effects. Although IFN-γ receptor (IFNGR)-deficient mice
(Ifngr1−/−) infected with either WNV or ZIKV exhibited no acute defects in CNS virological
control, spatial learning was preserved. Ifngr1−/− and Cd8−/− mice exhibited early recovery of
presynaptic termini expressing synaptophysin during recuperation from WNV infection. For
ZIKV, Ifngr1−/− and Cd8−/− mice exhibited decreased neuronal apoptosis with recovery of
postsynaptic termini that was most pronounced in the CA regions following viral clearance.
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Microglial-specific deletion of IFNGR protected mice against spatial-learning deficits and
blocked alterations in synapses or neuronal numbers induced during recovery from infection with
either virus. These results indicate that T cell and microglial interactions are critical for
triggering post-infectious cognitive dysfunction through effects on hippocampal circuitry.

3.3 Results
ZIKV preferentially targets the adult hippocampus.
To address the mechanisms of cognitive recovery from neuroinvasive infection with ZIKV, we
developed a model of ZIKV infection recovery in adult mice. Direct intracranial inoculation of
8-week-old C57BL/6J (wild-type (WT)) mice with ZIKV-Dakar (Dakar 41525, Senegal, 1984),
which shows increased pathogenicity, including higher levels of inflammatory cytokine
induction in mice, compared with Asian strains23, led to weight loss but 100% survival (Fig.
3.1a,,b).b). This was comparable to our established recovery model of infection with a mutant
WNV10, a strain in which a point mutation in NS5, a nonstructural protein that encodes a 2’-Omethyltransferase, prevents viral recognition by tetratricopeptide repeats 1 (IFIT1), which
normally acts to block translation of virion-delivered virus-specific RNAs24. ZIKV replicated to
high levels in the hippocampus and cortex, and, to a lesser extent, in the cerebellum (Fig. 3.1c).
Quantitative PCR (qPCR) analysis of hippocampal tissue during acute ZIKV infection and
recovery demonstrated robust induction of Cxcl10, Tnfa, and Il1a (Fig. 3.1d), which are
molecules known to play important roles during WNV infection of the CNS25. Detection of
ZIKV or WNV envelope protein (E) mRNA via in situ hybridization revealed dramatic
differences in viral tropism within forebrain regions. Robust levels of ZIKV E mRNA were
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detected within all regions of the hippocampi of all animals examined. By comparison, E mRNA
in WNV-infected mice was variably detected in multiple areas throughout forebrain and
hindbrain regions (Fig. 3.1e; Fig. 3.9a,b). Immunohistochemical (IHC) detection of viral proteins
within cellular targets of both viruses revealed that both WNV and ZIKV primarily targeted
mature neurons (Fig. 3.1f; Fig. 3.9c,d); however, ZIKV E protein was also detected within
NeuN+ cells near the neurogenic subgranular zone of the DG, suggesting that there is additional
targeting of immature neurons (Fig. 3.9e,f). These data suggest that direct intracranial infection
with ZIKV leads to high viral titers in the hippocampus and induces a neuroinflammatory
immune response in animals that survive infection, providing a robust model for recovery from
neurotropic viral infection.

ZIKV infection of the adult CNS is associated with loss of neurons.
Expression of cytokines and chemoattractant molecules within the virally infected CNS
promotes the recruitment and activation of antiviral T cells, which may persist after viral
clearance with unknown consequences26. A transcriptional microarray analysis of hippocampal
gene expression during recovery of WNV (25 days post-infection (d.p.i.)) indeed identified
pathways associated with adaptive immune responses. Genes involved in antigen processing and
presentation and in chemokine signaling10 were identified, which suggests that cytokines and
chemoattractant molecules persist beyond acute infection. Indeed, flow cytometry analysis of
CD45+ cells in the hippocampus during acute infection and after recovery from ZIKV and WNV
encephalitis revealed a large population of infiltrating lymphocytes (CD45hiCD11b−), which
were primarily CD8+ T cells, that persisted despite viral clearance (Fig. 3.10). Intraparenchymal
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T cells and activated astrocytes and microglia were detected robustly at all time points within the
hippocampus during recovery from ZIKV infection (Fig. 3.2a,c), whereas these cells were at the
highest levels at 25 d.p.i. with WNV (Fig. 3.2b,d). Consistent with prior work10, WNV infection
did not lead to neuronal loss in the hippocampus (Fig. 3.2b,d), although ZIKV infection led to a
significant decrease in NeuN+ cells during acute infection that plateaued by 25 d.p.i. (Fig.
3.2a,c). These data suggest these flaviviruses exert distinct immunopathological effects during
recovery.

Antiviral CD8+IFNg+ T cells associate with microglia in the post-infected hippocampus.
An analysis of infiltrating CNS T cells in mice at 25 d.p.i. with WNV or ZIKV revealed
significantly increased percentages of CD8+ T cells expressing the integrin CD103, which has
been associated with CNS Trm cell formation26 (Fig. 3.2e,f). Percentages of
CD45midCD11b+CX3CR1+CCR2− microglia expressing MHCII, a marker associated with
microglial activation that is induced by the T cell cytokine IFN-γ, were also significantly
increased (Fig. 3.2g,h). Consistent with this, the qPCR analysis revealed that
hippocampal Ifng expression increased following WNV and ZIKV infection, and remained
significantly elevated during recovery (Fig. 3.3a,c). An analysis of IFN-γ-YFP (yellow
fluorescent protein) reporter mice at 25 d.p.i. demonstrated that CD3+ T cells expressed the bulk
of IFN-γ in hippocampus at this time point, with IBA1+ microglia representing an additional
source (Fig. 3.3b,d). Flow cytometry analysis of CD45+IFN-γ+ cells isolated from the
hippocampus of IFN-γ-Thy1.1 reporter mice at 25 d.p.i. confirmed that ~15% of the cells were
CD45midCD11b+ microglia, while ~80% were CD45hiCD11b− lymphocytes, specifically CD8+ T
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cells (Fig. 3.3e–g). An analysis of CD8+IFN-γ +cells confirmed that a subpopulation of these
cells expressed CD103, while detection of NS4B, the predominant CD8 epitope in WNVinfected mice27, via tetramer staining confirmed virus specificity (Fig. 3.3f,g; Fig. 3.11). In
addition, IFN-γ+CD8+ T cells were observed in close proximity to CX3CR1+ microglia at 25
d.p.i. (Fig. 3.3h,i). An additional flow cytometry analysis of mice at 52 d.p.i. confirmed that
CD8+IFN-γ+ T cells persisted in the hippocampus 1 month after viral clearance (Fig. 3.11). These
data show that antiviral T cells reside in the hippocampus following flavivirus infection, and may
influence the reactivity of resident neural cell populations through cytokine signaling.

ZIKV- and WNV-infected mice show IFN-g-mediated deficits in spatial learning post
recovery.
While IFN-γ is critical for virological control within the CNS, it is also a dynamic regulator of
circuit plasticity18. Thus, we hypothesized that IFN-γ signaling between T cells and resident CNS
cells may underlie post-infectious cognitive sequelae. Mock, WNV, or ZIKV infection
of Ifngr1−/−and WT mice did not reveal significant differences in survival, weight loss, or clinical
score between these animal models (Fig. 3.12a–f). Consistent with the clinical course, the
kinetics of infectious viral replication in most brain regions of the CNS were similar between
WT and Ifngr1−/− mice following WNV and ZIKV infection (not shown), with the exception of
the cerebella in Ifngr1−/− animals, for which WNV clearance was significantly delayed, but
cleared in both genotypes by 24 d.p.i. (Fig. 3.12g–i). Mock-, WNV-or ZIKVinfected Ifngr1−/−and WT mice underwent cognitive behavioral testing 1 month following viral
clearance (Fig. 3.4a). WT mice exhibited spatial-learning deficits on the Barnes maze following
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WNV infection, as previously described10,13, as did those recovering from ZIKV infection,
while Ifngr1−/− mice were protected, showing similar learning curves to mock-infected controls
(Fig. 3.4b,c). To control for alterations in anxiety or movement that could impact performance in
hippocampus-dependent tasks, we also performed open-field tests (OFTs). While WNV infection
did not alter exploratory or anxiety-like behaviors during the OFT in WT or Ifngr1−/− mice (Fig.
4e,g), ZIKV-infected WT and Ifngr1−/− mice crossed more lines during the OFT than mockinfected controls (Fig. 3.4d), but did not show differences in anxiety (Fig. 3.4f). As this increase
in locomotion was observed in both genotypes, this change in behavior is unlikely to explain the
difference in the Barnes maze deficits observed between WT and Ifngr1−/− mice.
T cell-derived IFN-γ is required to achieve an antiviral state following antigen re-exposure22,
which is an important functional outcome for Trm cell generation. Of interest, we found that there
was decreased expression of the Trm cell marker CD103 in a subpopulation of
CD45hiCD11b−CD8+ T cells in the hippocampus of Ifngr1−/− animals post recovery from
infection compared with WT controls, with minimal CD103 expression in CD4+ T cells (Fig.
3.13a,b). We also found high levels of CCR2 on a subpopulation of CD45hiCD11b−CD8+ T cells
in the hippocampus of mice that had recovered from infection, the expression of which did not
change in the absence of IFN-γ signaling (Fig. 3.13c,d). Importantly, CCR2 expression by
CD3+ T cells has been demonstrated in human spinal cord tissue from cases of WNV
encephalomyelitis28; however, the functional consequence of CCR2 expression by T cells in the
CNS remains unknown. Together, these data suggest that IFN-γ signaling negatively affects
cognitive recovery from neurotropic viral infections, which is unlikely to be due to differences in
clinical disease or virological control.
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IFNGR signaling is required for neuronal apoptosis during recovery from ZIKV infection.
Given the dramatic hippocampal targeting and neuronal loss observed following ZIKV infection
(Figs. 3.1 and 3.2), we determined whether the altered survival of neural cells might underlie
spatial-learning deficits. At 25 d.p.i. with ZIKV, Ifngr1−/− and Cd8−/− mice exhibited
significantly higher levels of NeuN compared with similarly infected WT animals, in which
levels were reduced by ~30% of mock-infected controls (Fig. 3.5a–c). In comparison,
WT, Ifngr1−/−, and Cd8−/− mice had similar levels of detection of NeuN following recovery from
WNV infection (Fig. 3.5e–g). Consistent with prior studies10, we observed no ongoing neuronal
loss in WT animals post recovery from WNV infection (Fig. 3.5e–g). Consistent with the
observed loss of NeuN+ cells, TdT-mediated dUTP nick end labeled (TUNEL)+ cells in the DG,
CA3, and CA1 regions of the hippocampus of ZIKV-infected WT animals were significantly
increased post recovery compared with mock-and ZIKV-infected Ifngr1−/− animals post recovery
(Fig. 3.5h). Of note, levels of apoptosis within the DG were considerably lower and more
variable than that observed in other hippocampal regions (Fig. 3.5a,d,h). Within the CA3, which
is a region critical for spatial learning, detection of NeuN+TUNEL+ cells was significantly lower
in ZIKV-infected Ifngr1−/− and Cd8−/−mice compared with similarly infected WT animals after
viral clearance (Fig. 3.5i,j). ZIKV did not target GAD67+ GABAergic neuronal populations,
which suggests that the virus may not target interneurons (Fig. 3.14a). In contrast, there were no
significant differences in NeuN+TUNEL+ cells in the hippocampus of WT and Ifngr1−/− mice
post recovery from mock infection or WNV infection (Fig. 3.5k). ZIKV also did not alter the
number of new neurons born within the DG during recovery from infection, which suggests that
impairment in neurogenesis is not a contribution to long-term deficits (Fig. 3.14b). However,
increased neuronal loss and apoptosis persisted up to 52 d.p.i. in ZIKV-infected WT mice post
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recovery compared with mock-and ZIKV-infected Ifngr1−/− mice post recovery (Fig. 3.5l; Fig.
3.14d). These data indicate that WNV and ZIKV lead to differential effects on neurons,
including pathology, that contribute to defects in spatial learning.

IFNGR is required for synapse elimination during recovery from WNV infection via IL-1.
Prior studies have demonstrated that WNV infection leads to acute and chronic loss of
synaptophysin+ presynaptic terminals, but preservation of Homer1+ postsynaptic terminals,
which ceased by 52 d.p.i.10. In addition, expression of IL-1β by reactive astrocytes inhibits the
recovery of presynaptic termini and is associated with spatial-learning deficits during recovery
from WNV infection13. Given the synapse recovery observed in Ifngr1−/− mice and the
demonstration that IFN-γ influences IL-1β expression29, we examined levels of this cytokine in
WNV-infected Ifngr1−/− mice post recovery. Consistent with prior studies13, we detected
increased IL-1β expression by GFAP+ astrocytes in the hippocampus of WNV-infected WT mice
post recovery, which was significantly decreased in Ifngr1−/− animals at 25 d.p.i. (Fig. 3.6a). As
previously reported10, WNV-infected WT animals showed decreased synaptophysin+ presynaptic
terminals within the CA3 at 7 and 25 d.p.i., while WNV-infected Ifngr1−/− and Cd8−/− animals
demonstrated limited evidence of synapse elimination at either time point (Fig. 3.6b,c; Fig.
3.14e). This result suggests that IFNGR is required for synapse elimination during WNV
infection. In contrast, and consistent with acute and chronic loss of NeuN+ perikarya, ZIKV
infection led to loss of Homer1+ post-synaptic terminals in WT and Ifngr1−/− animals at 7 d.p.i.,
with preservation of synaptophysin + and vGlut+ presynaptic terminals (Fig. 3.14c,f,g). ZIKVinfected WT animals continued to exhibit decreased numbers of Homer1+ postsynaptic terminals
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within the CA3 at 25 and 52 d.p.i., while ZIKV-infected Ifngr1−/− animals exhibited recovery of
postsynaptic termini by 52 d.p.i. (Fig. 3.6d,e). ZIKV-infected WT and Ifngr1−/− animals also both
displayed significantly increased IL-1β expression by GFAP+ astrocytes in the hippocampus
compared with mock-infected controls post recovery (Fig. 3.15a). Of note, IL-1β expression was
not detected within IBA1+ cells at 25 d.p.i. (not shown). These data suggest that persistent
alterations in postsynaptic termini contribute to spatial-learning deficits in ZIKV-infected mice
independent of IL-1β signaling.

IFNGR signaling potentiates microglial engulfment of postsynaptic termini and perikaryal
in ZIKV-infected animals.
Phagocytic roles for microglia are well established and include removal of both apoptotic
newborn cells in the neurogenic niche of the hippocampus and non-apoptotic TBR2+ neural
progenitors in the developing cerebral cortex, in addition to synapse pruning and elimination, the
latter of which requires the upregulation of markers of microglial activation30. We therefore
wondered whether T cell-derived IFN-γ signaling is required for synapse elimination or neuronal
loss following WNV or ZIKV infection, respectively, via specific effects on microglia. Indeed,
both WNV and ZIKV infection led to increased expression of IBA1 at 25 d.p.i. in WT mice,
which did not occur in similarly infected Ifngr1−/− animals (Fig. 3.7a,b). Importantly, no
differences in numbers of CD45hiCD11b+CX3CR1+CCR2− microglia cells or expression of
TMEM119, a recently described homeostatic marker for microglia, were observed in WNV-and
ZIKV-infected WT and Ifngr1−/−animals post recovery (Fig. 3.15b–e). This result is consistent
with prior data demonstrating that viral infections do not promote microglial proliferation10.
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Flow cytometry analysis of CD45midCD11b+CX3CR1+CCR2− microglia revealed increased
expression of MHCII in WNV-and ZIKV-infected WT animals post recovery; this increased
expression was significantly attenuated in Infgr1−/− animals (Fig. 3.15f,g). This finding confirms
that IFN-γ contributes to microglial activation in the post-infectious CNS. Three-dimensional
reconstructions of IBA1+ cells from sections of ZIKV-infected mice at 25 d.p.i. revealed
Homer1+ puncta (Supplementary Video 1) and NeuN+ nuclei (Supplementary Video 2) within
microglia. Colocalization of Homer1 or NeuN, lysosomal-associated membrane protein 1
(LAMP1), and IBA1 revealed increased numbers of postsynaptic termini within the lysosomes of
IBA1+ cells, which were significantly reduced in Ifngr1−/− mice at 25 d.p.i. (Fig. 3.7c–f). These
data suggest that microglia may be critically involved in responses to T cell-derived IFN-γ that
drive cognitive impairment after infection with either WNV or ZIKV.

Micrgolial-specific deletion of IFNGR protects animals against spatial-learning defects.
Given the shared alteration in microglial activation observed in both WNV-and ZIKV-infected
animals post recovery in the absence of IFN-γ signaling, we utilized a conditional deletion
paradigm to determine whether IFN-γ signaling within microglia of mice post recovery was
responsible for the observed spatial-learning deficits. Cx3cr1CreERIfngrfl/fl (referred to as
Cre+hereafter) animals and Cx3cr1CreERIfngrfl/fl (referred to as Cre− hereafter) litter-mate controls
were mock-infected or infected with WNV or ZIKV, and then treated with tamoxifen 1 week
after infectious viral clearance (at 19 and 21 d.p.i.). Animals were allowed to recover for 3 weeks
to achieve specific deletion of Ifngr in long-lived microglia while allowing time for short-lived
CX3CR1-expressing myeloid populations to turnover31 (Fig. 3.16a–d), at which time cognitive
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behavior testing was performed (Fig. 3.8a). Similar to WT animals, tamoxifen-treated
Cre−animals displayed significant spatial-learning deficits on the Barnes maze following WNV
and ZIKV infection (Fig. 3.8b,c). In contrast, tamoxifen-treated Cre+ animals performed
similarly to mock-infected controls (Fig. 3.8b,c). OFTs confirmed no differences in locomotor
activity or anxiety between experimental groups, with the exception of an increase in activity in
ZIKV-infected WT animals, as previously shown (Fig. 3.8d–g). Importantly, microglial-specific
deletion of Ifngr after viral clearance was sufficient to prevent elimination of
synaptophysin+ presynaptic termini and neuronal apoptosis in WNV-and ZIKV-infected mice,
respectively (Fig. 3.8h,i). A lack of increased microglial MHCII expression was also observed in
WNV-and ZIKV-infected Cre+ mice post recovery (Fig. 3.16e,f), confirming that IFN-γ
signaling in microglia during recuperation promotes their continued activation. Together, these
data suggest that IFN-γ signaling in microglia contributes to microglial activation and spatiallearning deficits following clearance of infectious WNV and ZIKV from the CNS.

3.4 Discussion
Antiviral T cells persist within the CNS for months to years after neurotropic viral infections26.
The extent to which these tissue-resident cells impact on normal brain function is unclear;
however, studies of acutely infected mice suggest that CD8+ T cells may damage neuronal
structures, such as dendrites, during viral clearance32. Here, we developed a novel murine model
to evaluate mechanisms of cognitive decline following adult ZIKV infection. We found that
ZIKV preferentially targets and induces the loss of neurons throughout the hippocampus, which
was also associated with the loss of postsynaptic Homer1+ termini. In contrast, the related WNV,
which infects neurons throughout the CNS, led to elimination of synpato-physin+ presynaptic
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termini, which was most pronounced within the CA3 region of the hippocampus, as previously
described10,13. Survival after infection with either virus was associated with the recruitment of
antiviral CD4+ and CD8+ T cells, the latter of which persisted in the virus-cleared CNS,
expressed CD103, and became a predominant source of IFN-γ. While IFN-γ+CD4+ T cells also
persisted, targeted deletion of IFN-γ signaling or CD8 was sufficient for reversing the effects of
WNV and ZIKV infection on synapses and apoptosis, respectively. IFN-γ signaling was required
for synapse elimination during WNV infection and for the loss of neuronal cell bodies and
recovery of synapses after ZIKV infection. Levels of IFN-γ remained elevated after viral
clearance, and IFN-γ signaling was required for microglial activation and cognitive dysfunction
during recovery from infection with either virus. Microglia-specific deletion of Ifngr prevented
the development of WNV-or ZIKV-induced hippocampal-dependent learning and memory
deficits, suggesting that T cell signaling to microglia is a pivotal event in the development of
post-infectious cognitive dysfunction after recovery from flavivirus encephalitis (Fig. 3.17). We
used an inducible CX3CR1-Cre line (Cx3cr1 -CreERT) and administered tamoxifen 1 week after
viral clearance (~20 d.p.i.), when macrophages are no longer present in the CNS (Fig. 3.10). We
therefore designed this experiment to limit the possibility that non-microglial myeloid cells were
participating in the process. Nevertheless, as CXC3R1 is not a specific microglial marker, nonmicroglial cells could possibly contribute to the results obtained.
Infection with ZIKV appears to target the hippocampus in our model. The pathogenesis of ZIKV
infection is poorly understood, and there is considerable debate regarding the putative receptors
that enable ZIKV infection of various cell types. Several entry receptors, including the innate
immune receptor DC-SIGN, the transmembrane protein TIM-1, and TAM receptors (Tyro3, Axl,
and Mertk), a family of phosphatidylserine receptors, have been extensively studied for their
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potential role as flavivirus entry receptors33. However, a more recent study investigating different
infection routes of ZIKV, including subcutaneous, transplacental, vaginal, and intracranial
infections in WT and TAM receptor null mice, showed no difference in viral titers34. TAM
receptors, at least in mice, are therefore not essential for ZIKV infection, but may play roles in
viral tropism. Studies examining Tyro3 expression in the rodent CNS, however, have
demonstrated that it is specifically expressed within the neocortex, especially within the
hippocampus35. Thus, although Tyro3 is not required for ZIKV infection, the high level of
hippocampal expression of this receptor could potentially contribute to ZIKV targeting this CNS
region. ZIKV also led to extensive and ongoing neuronal apoptosis in the hippocampus, which
was attenuated in the absence of IFN-γ. This is consistent with studies of mice with CNS
autoimmune disease, in which IFN-γ is observed to directly induce apoptosis of
oligodendrocytes36. Alternatively, activated microglia can promote apoptosis by inducing
phosphatidylserine exposure and subsequent phagocytosis of neurons by Mertk37. The
differential extent of neuronal apoptosis and recovery in ZIKV-infected WT, Ifngr1−/−,
and Cd8−/− mice supports reports that a threshold number of neurons may be needed to achieve
spatial learning38. Resolution of neuroinflammation may involve FasL-mediated apoptosis of T
cells39, which may explain the increased numbers of TUNEL+ cells that are not neurons.
The persistence of presynaptic termini after ZIKV infection suggests that synaptic boutons of
injured axons of hippocampal neurons may be resistant to the rapid loss incurred by other
cortical neurons40. This also suggests that microglial activation following viral infection does not
universally lead to elimination of presynaptic termini, even among closely related virus family
members, and that mechanisms leading to microglial-mediated phagocytosis of synapses or
neuronal nuclei may be distinct41. Elimination of presynaptic termini following WNV infection
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requires the complement component C3 and its receptor C3aR10. Astrocytic C3 induces C3aRmediated phagocytosis in a model of AD, but this is attenuated with prolonged exposure to C3
(ref. 42), which may explain the lack of elimination of presynaptic termini in the setting of the
observed robust and persistent ZIKV-induced astrogliosis.
Loss of IFN-γ signaling also led to attenuation of astrocyte activation during recovery from
WNV, but not ZIKV, infection. The lack of astrocyte activation in Ifngr1−/− animals protected
animals against astrocyte IL-1β production13, which limits synapse repair during recovery from
WNV infection13. This effect could be caused by a direct loss of IFN-γ signaling in astrocytes, or
it could be secondary to the lack of microglial activation43. In our model, the latter explanation is
more probable given that specific deletion of Ifngr in microglia was sufficient to protect animals
against spatial-learning deficits, and prior work has demonstrated that in Csflr−/− mice, which
lack microglia, lipopolysaccharide injection fails to activate astrocytes44. These studies suggest
that signaling between microglia and astrocytes critically regulates ongoing neuroinflammation
following viral clearance. That spatial learning is preserved in ZIKV-infected Ifngr1−/− animals
post recovery despite widespread astrocyte reactivity and IL-1β production, which is pathogenic
in WNV-infected animals post recovery, adds to the growing body of work demonstrating that
heterogeneity in astrocyte reactivity can promote or prevent CNS repair in a disease-specific
manner44.
Although the full spectrum of clinical complications after infection with ZIKV remains unclear,
the incidence of neurological manifestations is increasing, including reports of cognitive
sequelae45,46. Our study also detected increased motor activity in ZIKV-infected mice post
recovery. Of interest, neuropsychiatric symptoms, including hyperactivity and hypomania, have
been reported in a young adult presenting with ZIKV encephalitis46. This finding suggests that
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ZIKV targeting of the hippocampus may influence cognitive functions beyond spatial learning.
Cognitive dysfunction after recovery from WNV infection was first reported in the United States
approximately 8 years after its emergence in the New York area47, and numerous clinical studies
since that time have documented persistent psychological and cognitive sequelae following
WNV infection1. Moreover, the induced cognitive sequelae may worsen over time1. In humans,
male sex is independently associated with developing neuroinvasive disease and death,
especially in older individuals48. While no studies have addressed sex differences in cognitive
outcomes, higher survival rates of female patients could impact potential findings. In our study,
we used both male and female animals in numbers powered to assess cognitive dysfunction but
not sex differences. Further studies of both humans and rodents are needed to examine sexually
dimorphic features of neurological sequelae after flavivirus encephalitis.
The differential effect of global versus cell-specific deletion of IFNGR on locomotor activity in
ZIKV-infected mice suggests that cell-specific roles for this receptor in motor activity may occur
during recovery. In addition to microglia, IFNGR is also expressed by astrocytes, neurons, and
brain microvasculature, which may each exhibit regional differences in their levels of expression
and/or signaling pathways. Given that ZIKV also targets axons in the pyramidal tract (Fig. 3.1e),
it is possible that effects on motor activity are mediated by any of these cell types within this
brain region. As microglial-specific deletion of IFNGR abolished hyperactivity, it is possible that
IFNGR signaling in microglia specifically limits the effects of the virus on motor function. As
the effect was not abolished in mice with global IFNGR deletion, it is possible that IFNGR
signaling of other cell types might override the effects of microglia. Additional studies
examining regional and cell-specific differences in IFNGR signaling are needed to determine the
mechanism of this effect.
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In summary, our studies demonstrate that re-establishing circuit integrity through recovery of
lost synapses or neurons is critical for restoring hippocampal function after injury, and identify
IFN-γ signaling to microglia as a proximal regulator of this repair in the post-infectious CNS.
Given the recent association of herpesviral infections49 and T cells50 within the CNS parenchyma
of patients with AD, the mechanisms uncovered in our study could have implications for other
types of memory disorders.

3.5 Methods
Animals
Male and female mice (8–10 weeks old) were used for each experiment. C57BL/6J, Ifngr1−/−,
Ifngrfl/fl and CX3CR1-CreERT mice were obtained from Jackson Laboratories. Transgenic animals
were backcrossed more than ten generations to C57BL/6 mice at Jackson Laboratories. IFN-γYFP (C57BL/6 background) and IFN-γ-Thy1.1 (C57BL/6 background) were obtained from H.
Shin at Washington Univeristy in St. Louis. CX3CR1GFPCCR2RFP mice were obtained from R.
Ransohoff and the Lerner Research Institute and crossed in-house to Ifngr1−/− mice to
generate Ifngr1−/−CX3CR1GFPCCR2RFP reporter mice. All experiments followed the guidelines
approved by the Washington University School of Medicine Animals Safety Committee (protocol
no. 20170064).

Mouse models of WNV infection.
WNV-NS5-E218A and ZIKV-Dakar strains utilized for intracranial infections were obtained from
M. Diamond at Washington University in St Louis. WNV-NS5-E218A contains a single point
mutation in the gene encoding 2’-O-methyltransferase. Mice were deeply anesthetized and
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intracranially administered 1 X 104 plaque-forming units (p.f.u.) of WNV-NS5-E218A or ZIKVDakar. Viruses were diluted in 10 μl of 0.5% fetal bovine serum in Hank’s balanced salt solution
(HBBS) and injected into the third ventricle of the brain with a guided 29-guage needle. Mockinfected mice were intracranially injected with 10 μl of 0.5% in HBSS into the third ventricle of
the brain with a guided 29-guage needle. BHK21 cells were used for viral plaque assays to
determine stock titers of both viruses (described below).

Measurement of viral burden.
WNV-or ZIKV-infected mice were killed and tissues were collected, weighed, homogenized with
zirconia beads in a MagNA Lyser instrument (Roche Life Science) in 500 μl of PBS, and stored
at −80 °C until virus titration. Thawed samples were clarified by centrifugation (2,000 × g at 4 °C
for 10 min), and then diluted serially before infection of BHK21 cells. Plaque assays were overlaid
with low-melting point agarose, fixed 4 days later with 10% formaldehyde, and stained with crystal
violet. Viral burden was expressed on a log10 scale as p.f.u. per gram of tissue. During initial
development of the adult ZIKV infection and recovery model (Fig. 3.9), viral burden was
determined by qPCR with reverse transcription (qRT-PCR). RNA was extracted using a RNeasy
Mini kit (Qiagen). ZIKV levels were determined by one-step qRT-PCR on an Applied Biosystems
ViiA7 Real-Time PCR system using standard cycling conditions. A standard curve was produced
using serial tenfold dilutions of ZIKV RNA, and viral burden was expressed as viral RNA
equivalents per gram of tissue.

Immunohistochemistry.
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Mice were anesthetized and perfused with ice-cold Dulbecco’s PBS (Gibco) followed by ice-cold
4% paraformaldehyde (PFA). Brains were post-fixed overnight in 4% PFA followed by
cyroprotection in 30% sucrose (three exchanges for 24 h), then frozen in OCT compound (Fischer).
Coronal tissue sections (10 μm) were washed with PBS and permeabilized with 0.1–0.3% Triton
X-100 (Sigma-Aldrich). Nonspecific antibodies were blocked with 5% normal goat serum (SigmaAldrich) at room temperature for 1 h. To reduce endogenous mouse antibody staining when
detecting ZIKV, a Mouse on Mouse kit (MOM basic kit, Vector) was used as per the
manufacturer’s instructions. Slides were then incubated in primary antibody (described below) or
isotype-matched IgG overnight at 4 °C. Following washes in PBS, slides were then incubated in
secondary antibodies at room temperature for 1 h, and nuclei were counterstained with 4,6diamidino-2-phenylindole (DAPI; Invitrogen). Coverslips were applied with ProLong Gold
Antifade Mountant (Thermo Fisher). Immunofluorescent images were acquired using a Zeiss LSM
880 confocal laser scanning microscope and processed using software from Zeiss.
Immunofluorescent signals were quantified using the software ImageJ.

Antibodies for immunohistochemistry.
The following primary antibodies were used for IHC analyses: WNV (1:100, polyclonal25), ZIKV
(1:50; gift from M. Diamond (St. Louis, MO), ZV-13), NeuN (1:1,000; Cell Signaling, cat no.
12943S, clone D3S3I), BrdU (1:200; Abcam, cat. no. ab1893, polyclonal), doublecortin (1:125;
Cell Signaling, cat. no. 4604S, polyclonal), GFAP (1:250; Thermo, cat. no. 13–0300, clone
2.2B10), IL-1β (1:100; R&D, cat. no. AF-401, polyclonal), CD3 (1:250; R&D, cat. no. MAB4841,
clone 17A2), CD11c (1:50; Novus, cat. no. NB110– 97871, clone AP-MAB0806), GFP (1:500;
Abcam, cat. no. ab13970, polyclonal), IBA1 (1:200; Wako, cat. no. 019–19741, polyclonal),
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TMEM119 (1:200; Abcam, cat. no. ab209064, clone 28–3), TUNEL (Roche In situ Cell Death kit
Red), and synaptophysin (1:250; Synaptic Systems, cat. no. 101004, polyclonal). Secondary
antibodies conjugated to Alexa-488 (Invitrogen, cat. no. A-21206, polyclonal) or Alexa-555
(Invitrogen, cat. no. A-21435, polyclonal) were used at a 1:400 dilution.

Three-dimensional reconstruction of confocal z-stack images.
Confocal z-stack images were taken using a Zeiss LSM 880 laser scanning microscope with
Airyscan at ×63 magnification, and consisted of at least eight images. Images were transformed
into three-dimensional reconstruction videos using the image analysis software Volocity 3D
image.

RNAscope in situ hybridization.
Mice were anesthetized and perfused with ice-cold PBS. Brains were then immersion-fixed
overnight in 4% PFA followed by three exchanges of 30% sucrose for 24 h. Brains were
embedded in OCT compound (Fischer) and 10-μm sagittal tissue sections were prepared.
RNAscope 2.5 HD Assay-Brown was performed as per the manufacturer’s instructions. Probes
against WNV and ZIKA mRNA (ACD) were used. Viral tropism was analyzed using a ZEISS
Axio Imager Z2 fluorescence microscope.

Flow cytometry.
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Cells from the hippocampus and cortex of mice were isolated at indicated d.p.i. and stained with
fluorescence-conjugated antibodies (described below) as previously described13. Briefly, mice
were anesthetized and perfused with ice-cold Dulbecco’s PBS (Gibco). Hippocampal and cortex
brain tissue were dissected out, minced, and enzymatically digested at room temperature for 1 h
with shaking. The digestion buffer contained collagenase D (Sigma, 50 mg ml−1), TLCK trypsin
inhibitor (Sigma, 100 μg ml−1), DNase I (Sigma, 100 U μl−1), HEPES buffer, pH 7.2 (Gibco, 1 M)
in HBSS (Gibco). The tissue was then pushed through a 70-μm strainer and pelleted by a 500
× gspin cycle for 10 min. To remove myelin debris, cells were resuspended in 37% Percoll and
spun at 1,200 × g for 30 min. Cells were then resuspended in FACS buffer. TruStain fcX antimouse CD16/32 (BioLegend, cat. no. 101320, clone 93) was used to block the cells for 5 min at 4
°C, followed by cell surface staining for 15 min at 4 °C. Cells were washed twice in FACS buffer,
fixed with 4% PFA, and resuspended in 2% PFA for data acquisition. Data were collected using a
Fortessa X-20 instrument and analyzed with the software Flowjo.

Antibodies for flow cytometry.
The following antibodies were used for flow cytometry: CD45 (PE/Cy7, BioLegend, cat. no.
103114, clone 30-F11), CD11b (Brilliant Violet 605, BioLegend, cat. no. 101257, clone M1/70),
I-A/I-E (MHC-II, APC/Cy7, BioLegend, cat. no. 107628, clone M5/114.15.2), CD4 (Alexa Fluor
700, BioLegend, cat. no. 100536, clone RM4–5), CD8 (PerCP/Cy5.5, BioLegend, cat. no.
100734, clone 53–6.7), NK1.1 (Brilliant Violet 421, BioLegend, cat. no. 108741, clone PK136),
CD103 (APC, BioLegend, cat. no. 121414, clone 2E7), Thy1.1 (PE, BioLegend, cat. no. 202524,
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clone OX-7), CD119 (IFNGR, Biotin, BD Biosciences, cat. no. 558771, clone GR20), and
streptavidin (PE, BD Biosciences, cat. no. 554061).

Behavioral testing.
Animals underwent open-field and Barnes maze testing as previously described13. Briefly, mice
were given 3 min to explore the Barnes maze platform and to find the target hole. If a mouse did
not find the target hole within the test period, it was gently guided in the hole. At the end of a
trial, the mice remained in the target hole for 1 min before being placed back into their home
cage between trials. Each mouse received two trials per day over the course of five consecutive
days. The number of errors (or number of nose pokes over non-target holes) was recorded.
Before Barnes maze testing, animals performed the OFT as a measure of exploratory behavior.
Each mouse was given 5 min to explore an empty arena before being placed back into its home
cage. Both the Barnes maze platform and the open-field arena were decontaminated with 70%
ethanol between trials and/or mice. All trials were video recorded using a camera (Canon
Powershot SD1100IS) and scored by experimenters blinded to the treatment conditions.

Statistical analysis.
Unpaired Student’s t-test or one-way or two-way analysis of variance (ANOVA) with
appropriate post-test to correct for multiple comparisons, in which the means of all groups were
compared pairwise, were performed as indicated in the figure legends. Prism 7.0 (GraphPad
Software) was used for generating graphs and statistical analyses. P values of ≤0.05 were
94

considered significant. To determine sample sizes for virological and immunological studies, a
power analysis was performed using the following values: probability of type I error = 0.05,
power = 80%, fivefold hypothetical difference in mean, and population variance of 25-fold
(virological studies) or 12-fold (immunological studies). Sample sizes for behavioral testing
experiments were predetermined by the power analysis. For all experiments, animals were
randomly assigned to mock, WNV or ZIKV infection. Investigators were blinded to group
allocation during data collection and analyses.
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3.8 Figures

Figure 3.1. ZIKV targets the hippocampus.
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a-d, Establishing a mouse model of adult ZIKV infection and recovery. a, ZIKV infection did
not cause lethality in adult mice. b, ZIKV infection led to weight loss, expressed as the
percentage of day 0 body weight. Data were pooled from two independent experiments (n = 10
mice per group; P< 0.0001). c, ZIKV replicated in the CNS of WT mice. Viral burden was
quantified via standard plaque assays (n = 5 mice per group; P = 0.0001 for the frontal corext
and hippocampus). P.f.u., plaque-forming units. d, ZIKV infection induced cytokine responses in
the hippocampus. qPCR analysis of indicated mRNA isolated from the hippocampus at the
indicated d.p.i. (n = 5 mice per group). Cxcl10 (left to right), P= 0.0048 and 0.0007; Tnfa, P<
0.0001; Il1a (left to right), P = 0.0010 and 0.0002. e,f, ZIKV and WNV target different regions
of the CNS during acute infection, but similarly infect mature neurons in the hippocampus. e, In
situ hybridization for viral RNA at 7 d.p.i. revealed dramatic differences in the neurotropism of
WNV and ZIKV. ZIKV consistently targeted the hippocampus, with sparse infection of the
cortex and striatum. Conversely, WNV RNA was present throughout the CNS, including the
olfactory bulb, cortex, hippocampus, and cerebellum. Representative images shown (n = 4 mice
per group) here, with additional images shown in Supplementary Fig 1. Scale bars,1,000 μm. f,
ZIKV and WNV target mature neurons in the hippocampus. Representative immunostaining of
the CA3 region of the hippocampus for NeuN (green), viral antigen (red), and DAPI (blue). Data
are representative of one independent experiment. Scale bar, 20 μm. For b-d, data represent the
mean ± s.d. and were analyzed by two-way (b) or one-way (c and d) ANOVA, and corrected for
multiple comparisons. **P< 0.005, ***P< 0.001, ****P<0.0001.
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Figure 3.2. ZIKV induces neuroinflammation and neuronal loss in the hippocampus.
a-d, ZIKV and WNV induce differential neuropathology in the hippocampus of WT mice. IHC
analysis revealed that the number of microglia (IBA1+), astrocytes (GFAP+), and T cells (CD3+)
increases in the hippocampus after infection with either virus, but the number of neurons
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(NeuN+) decreases following ZIKV infection. a,b, Representative images shown. Scale bars, 20
μm. c,d, The number of cells were quantified as indicated. For c, n = 3 (0 d.p.i.) or 5 (7, 25
d.p.i.) mice per group. IBA1, P = 0.0051 (0 versus 7d.p.i.) and P= 0.0001 (0 versus 25d.p.i.);
GFAP, P = 0.0086 (0 versus 7d.p.i.) and P = 0.0008 (0 versus 25 d.p.i.); CD3, P = 0.0001 (0
versus 25 d.p.i.); NeuN, P = 0.0342 (0 versus 7d.p.i.) and P= 0.0046 (0 versus 25 d.p.i.).
For d, n = 3 (0,25) or 4 (7d.p.i.) mice per group. IBA1, P = 0.0125; CD3, P = 0.0367. e-h, T
cells persist in the hippocampus after viral clearance, and microglia demonstrate persistent
activation. Flow cytometry analysis of cells isolated from the hippocampus of
CC3CR1GFPCCR2RFPreporter animals at the indicated d.p.i. (gating strategy shown
in Supplementary Fig 2). Data are representative of two independent experiments. e,f, ZIKV (e)
and WNV (f) infection leads to increased expression of CD103 in CD45hiCD11b−CD8+ T cells
(n = 3 mice per group; P<0.0001). g,h, CD45midCD11b+Cx3CR1+CCR2− microglia isolated from
the hippocampus of ZIKV-infected (g) and WNV-infected mice (h) express high levels of
MHCII at 25 d.p.i. (n = 3 mice per group; P= 0.0035 (g) and P = 0.0023 (h)). For c-h, data
represent the mean±s.d. and were analyzed by two-way ANOVA, corrected for multiple
comparisons (c and d) or by unpaired two-sided t-test (e-h). *P<0.05, **P< 0.005, ***P< 0.001,
****P< 0.0001.
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Figure 3.3. T cells express IFN-g in the post-infected hippocampus.
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a,c, qPCR analysis of Ifng expression in the hippocampus at the indicated d.p.i. For a, n = 4 (0,
7 d.p.i.) or 5 (25, 52 d.p.i.) mice per group. For c, n = 4 (0, 25d.p.i.), 3 (7 d.p.i.), or 5 (52 d.p.i.)
mice per group. For a (left to right), P = 0.0001 and P= 0.0376. For c (left to right), P =
0.0021, P= 0.0001, and P = 0.0145. b-g, IFN-γ is primarily expressed by CD3+CD8+ T cells at
25 d.p.i. b,d, Immunostaining (left) and quantitation (right) of hippocampi at 25d.p.i. from IFNγ-YFP reporter mice for IFN-γ (YFP) and cell-type-specific markers for neurons (NeuN),
astrocytes (GFAP), microglia (IBA1), and T cells (CD3) to identify the source of IFN-γ in the
hippocampi of infected mice post recovery. Images in the upper panel are magnifications of the
boxed area in the corresponding images in the lower panel. Scale bars, 20 μm. For b, n = 5 mice
per group; P = 0.0143 (NeuN versus GFAP) and P< 0.0001 (for other comparisons). For d, n = 4
mice per group; P = 0.0439 (NeuN versus GFAP) and P< 0.0001 (for other comparisons). e-g,
CD45+IFN-γ+ cells isolated from the hippocampus of IFN-γ-Thy1.1 reporter mice at 25d.p.i. e,
Gating strategy. Cells were gated via CD45 and CD11b to identify putative microglial (P1:
CD45midCD11b+), macrophage (P2: CD45hiCD11b+), and lymphocyte (P3: CD45hiCD11b−)
populations among IFN-γ-expressing cells. Population P3 was further analyzed for CD4, CD8,
and NK1.1 expression. IFN-γ+CD4+ and IFN-γ+CD8+ T cells were further analyzed for CD103
expression, and IFN-γ+CD8+ T cells were analyzed for virus specificity via NS4B tetramer
staining. f,g, Quantification of indicated populations (n = 4 mice per group). For f, P = 0.0402
(P1 versus P2), P< 0.0001 (for other comparisons), P= 0.0011 (P3: CD4 versus CD8), and P =
0.0006 (CD103+: CD4 versus CD8). For g, P< 0.0001 (for other comparisons) and P = 0.0002
(CD103+: CD4 versus CD8). Full gating strategy and absolute numbers are provided
in Supplementary Fig 3. h,i, IFN-γ+CD8+ T cells are closely associated with microglia in the
post-infectious CNS. Representative immunostaining of the CA3 region of the hippocampus for
IFN γ, CD8, IBA1, and DAPI. Data are representative of one independent experiment. For a-d, f,
and g, data represent the mean±s.d. and were analyzed by one-way ANOVA and corrected for
multiple comparisons. *P<0.05, **P< 0.005, ***P<0.001, ****P<0.0001.
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Figure 3.4 Loss of IFN-g signaling protects animals against spatial-learning deficits.
a-g, WT mice display spatial-learning deficits 1 month after viral clearance. lfngr1−/− animals
are protected against these deficits. Data were pooled from four independent experiments, with
the sample size for each group indicated in b and c. a, Schematic of the model of viral infection
and recovery. b,c, Average errors on the Barnes maze (sample sizes are indicated). For b, P =
0.0012 (WT mock versus ZIKV) and P = 0.0381 (lfngr1−/− mock versus ZIKV). For c, P<0,0001
(WT mock versus ZIKV) and P= 0.0186 (lfngr1−/− mock versus ZIKV). d-g, Open-field data to
assess locomotor activity (lines crossed; d,e) and anxiety (center crosses; f,g) in 5 min when
exploring an open-field arena (for sample sizes, see the corresponding colors in b and c).
For d (left to right), P = 0.0032 and P= 0.0059. For b-g, data represent the mean±s.e.m. and were
analyzed by two-way ANOVA, and corrected for multiple comparisons. *P<0.05, **P< 0.005,
****P< 0.0001.
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Figure 3.5 IFN-g promotes neuronal apoptosis in ZIKV-infected animals post recovery.
a-h, ZIKV, but not WNV, infection leads to decreased numbers of hippocampal neurons at 25
d.p.i. More neurons were found in infected Ifngrl−/− and Cd8−/− mice post recovery. a-c,e-g,
Representative images (a,e) and quantitation (b,c,f,g) of neurons in the hippocampus. Data were
pooled from two to three independent experiments. For b, n = 4 (WT mock, WT
ZIKV, Ifngrl−/− ZIKV) or 5 (Ifngr7−/− mock) mice per group. For c, n = 5 (WT mock) or 4 (WT
ZIKV, Ifngrl−/− mock, Ifngrl−/− ZIKV) mice per group. For f, n = 5 (WT mock, Ifngr7−/− mock),
7 (WT WNV), or 3 (Ifngr1−/− ZIKV) mice per group. For g, n = 5 (WT mock, WT ZIKV), 4
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(Ifngrl−/− mock), or 3 (Ifngrl−/− ZIKV) mice per group. For b(left to right), P= 0.001, P= 0.0111,
and P = 0.0214. For c, P= 0.0032. Scale bars, 200μm. d,h, Quantitation of TUNEL+ cells in
multiple regions of the hippocampus at 25 d.p.i. following ZIKV and WNV infection of WT
and Ifngrl−/− mice. Note that levels of apoptosis were much lower in WNV-infected animals post
recovery. Data were pooled from two independent experiments (n = 4 mice per group).
For d (left to right), P = 0.0009, P = 0.0001, and P = 0.0001. For h (left to right), P =
0.0138, P= 0.0002, and P = 0.0068. i,j, ZIKV infection leads to significant increases in
TUNEL+NeuN+ cells, which is not observed in Ifngrl−/− or Cd8−/− mice post recovery. Data were
pooled from two independent experiments. For i, n = 5 mice per group; P = 0.0049 and P =
0.0134 (left to right). For j, n = 4 mice per group; P = 0.0014 and P = 0.0081 (left to right). k,
Quantitation of TUNEL+NeuN+ cells at 25 d.p.i. with WNV. Data were pooled from two
independent experiments (n = 5 (WT mock, Ifngrl−/− mock), 7 (WT WNV), or 3 (Ifngrl−/− WNV)
mice per group). l, Quantitation of TUNEL+NeuN+ in ZIKV-infected WT versus Ifngrl−/− mice at
52d.p.i. Data were pooled from two independent experiments (n = 4 mice per group; P< 0.0001).
Scale bars, 20 μm. For b-d, f-l, data represent the mean±s.d. and were analyzed by two-way
ANOVA, and corrected for multiple comparisons (b-h). *P<0.05, **P<0.005, ***P<0.001.
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Figure 3.6 IFNGR is required for repair of presynaptic and postsynaptic termini in
flavivirus-infected animals post recovery.
a-c, WNV infection induces astrocyte IL-1β production, which leads to delayed recovery of
synapses in the hippocampus at 25 d.p.i. in WT mice, but Ifngrl−/− and Cd8−/− animals display
early recovery of presynaptic termini. a, Representative immunostaining (left) and quantitation
(right) of the hippocampus. Data were pooled from three independent experiments (n = 9 (WT
mock), 6 (WT WNV, Ifngrl−/− mock), or 4 (Ifngrl−/− WNV) mice per group; P<0.0001 (left)
and P= 0.0040 (right)). Scale bar, 50 μm. b,c, Representative immunostaining (left) and
quantitation (right) of the hippocampus at 25d.p.i. Data were pooled from three independent
experiments. For b, n = 9 (WT mock), 6 (WT WNV, Ifngrl−/− mock), or 4 (Ifngrl−/− WNV) mice
per group; P = 0.0311 (left) and P = 0.0169 (right). For c, n = 5 (WT mock), 3 (WT WNV), or
4 (Ifngrl−/− Mock, Ifngrl−/− WNV) mice per group; P = 0.0048 (left) and P = 0.0157 (right). Scale
bars, 50 μm. d,e, ZIKV infection leads to chronic loss of Homer1+ postsynaptic terminals at 25
and 52 d.p.i. in WT mice, but Ifngrl−/− animals display recovery. d, Representative
immunostaining (left) and quantitation (right) of the hippocampus at 25d.p.i. Data were pooled
from two independent experiments (n = 4 mice per group; P= 0.0011 (left) and P = 0.0311
(right)). Scale bar, 10μm. e, Representative immunostaining (left) and quantitation (right) of the
hippocampus at 52 d.p.i. Data were pooled from two independent experiments (n = 6 (WT
mock), 4 (WT WNV, Ifngrl−/− WNV), or 7 (Ifngrl−/− Mock) mice per group). Scale bar, 10 μm.
For all panels, data represent the mean±s.d. and were analyzed by two-way ANOVA, and
corrected for multiple comparisons. *P<0.05, **P<0.005, ****P<0.0001.
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Figure 3.7. IFN-g potentiates microglial engulfment of postsynaptic termini and neurons in
ZIKV-infected animals post recovery.
a,b, WNV or ZIKV infection induces increased expression of IBA1 in the hippocampus at
25d.p.i., which is significantly reduced in Ifngrl−/− mice. Representative immunostaining (left)
and quantitation (right) of the hippocampus at 25d.p.i. Data were pooled from two independent
experiments. For a, n = 4 mice per group; P=0.0001 (left) and P = 0.0102 (right). For b, n = 4
(WT mock, WT WNV, Ifngrl−/−WNV) or 6 (Ifngrl−/− mock) mice per group; P< 0.0001 (left)
and P = 0.0010 (right). Scale bars, 50 μm. c,e, IBA1+ microglia engulf postsynaptic termini at
25d.p.i., which is significantly reduced in Ifngrl−/−mice. Representative immunostaining, with
single-channel images on the right (c) and quantitation (e) of the hippocampus of infected mice
post recovery. Data were pooled from two independent experiments (n= 3 (WT
Mock, Ifngrl−/− Mock), 5 (WT ZIKV), or 4 (Ifngrl−/− ZIKV) mice per group; P= 0.0011 (left)
and P = 0.0209 (right)). Scale bars, 10 μm. d,f, IBA1+ microglia engulf NeuN+ perikarya at
25d.p.i., which is reduced in Ifngrl−/− mice. Representative immunostaining, with single-channel
images on the right (d) and quantitation (f) of the hippocampus of infected mice post recovery.
Data were pooled from two independent experiments (n = 4 (WT Mock, Ifngrl−/− ZIKV), 5 (n =
WT ZIKV), or 3 (Ifngrl−/−Mock) mice per group; P = 0.0190). Scale bars, 10μm. For a, b, e,
and f, data represent the mean±s.d. and were analyzed by two-way ANOVA, corrected for
multiple comparisons. *P<0.05, ***P< 0.001, ****P< 0.0001.
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Figure 3.8 Loss of IFN-g signaling in microglia during recovery protects animals against
spatial-learning deficits.
a-g, Specific deletion of IFNGR in microglia after viral clearance is sufficient to protect animals
against WNV-or ZIKV-induced spatial-learning deficits. a, Experimental
design. Cx3cr1CreERIfngrfl/fl (Cre+) animals were generated, and Cx3cr1CreERIfngrfl/fl (Cre−)
littermates were used as controls. Mice were challenged intracranially with mock, WNV, or
ZIKV at 8 weeks of age. All mice were treated with tamoxifen at 19 and 21 d.p.i. to induce Crerecombinase expression and achieve deletion of Ifngr in CX3CR1+ microglia. Behavioral testing
began on 45 d.p.i. with OFTs, followed by 5 consecutive days of Barnes maze testing. b,c,
Average errors on the Barnes maze. Data were pooled from four independent experiments, and
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sample sizes are as listed. For b, P= 0.0011 (Cre− mock and ZIKV) and P = 0.0073 (Cre+ mock
and ZIKV). For c, P = 0.003 (Cre− mock and ZIKV) and P= 0.0207 (Cre+ mock and ZIKV). d-g,
OFT data to assess locomotor activity (lines crossed; d,e) and anxiety (center crosses; e,g) in 5
min when exploring an open-field arena. Data were pooled from four independent experiments
(for sample sizes, see the corresponding colors in b and c); P = 0.0146 (d). h,i, Specific deletion
of Ifngr in microglia after viral clearance is sufficient to protect animals against WNV-or ZIKVmediated synapse and neuronal loss, respectively. Cre+ and Cre− littermates were infected with
mock, WNV, or ZIKV and treated with tamoxifen as described above, but tissue was collected at
25 d.p.i. for IHC analysis of synaptophysin or NeuN and TUNEL positivity. Data were pooled
from two independent experiments. For h, n = 7 (Cre− Mock), 4 (Cre− WNV, Cre+ WNV), or 5
(mock Cre+) mice per group. For i, n = 4 (Cre− mock, Cre− ZIKV, Cre+ mock) or 5 (Cre+ ZIKV)
mice per group. Scale bars, 20 μm. Data represent the mean±s.e.m. (b and c) or mean±s.d. (d-i)
and were analyzed by two-way ANOVA, and corrected for multiple comparisons (a-i). *P<0.05,
**P< 0.005, ***P< 0.001, ****P< 0.0001.
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Figure 3.9. ZIKV targets the hippocampus.
(a,b) ZIKV preferentially targets the hippocampus (white box). Additional representative images
of in situ hybridization for viral RNA (RNA-ISH) at 7 dpi as in Fig 1e, (n=4 mice per group).
(c,d) Neither WNV nor ZIKV targets astrocytes (GFAP+) or microglia (IBA1+) in the CA3
region of the hippocampus. (e,f) Neither WNV nor ZIKV targets neural progenitor cells (DCX+)
but does infect NeuN+ cells in the dentate gyrus of the hippocampus. Scale bar 20 µm.
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Figure 3.10. Kinetics of immune cell infiltration to the hippocampus.
Cx3CR1GFPCCR2RFP reporter animals were infected with WNV or ZIKV at 8 weeks old. Cells
were isolated from the hippocampus at indicated dpi. (a) Gating strategy to identify putative
microglia (P1: CD45midCD11b+), macrophage (P2: CD45hiCD11b+), and lymphocyte (P3:
CD45hiCD11b-) populations. (b,c) Quantification of indicated populations at 0, 7, and 25 dpi
revealed infiltration of putative macrophage and lymphocyte populations by 7 dpi, the latter of
which persisted in the hippocampus at 25 dpi. Data are representative of two independent
experiments (n=3 mice per group, mean + SD). (d) Additional gates were applied to P1 and P3
populations to assess MHC-II expression in CD45midCD11b+Cx3CR1+CCR2- microglia
populations and CD103 expression in CD45hiCD11b- CD8+ T cells (quantification in main Figure
2). (e,f) CD45hiCD11b- CD8+ T cells (identified by gating strategy in a,d) enter the hippocampus
by 7 dpi and persist to 25 dpi (n=3 mice per group, mean + SD). Data was analyzed by two-way
(b,c) or one-way (e,f) ANOVA, and corrected for multiple comparisons. *,P<0.05, **, P<0.005,
***, P<0.001, ****, P<0.0001.
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Figure 3.11 IFN-g+ T cells persist in the hippocampus.
Most of the IFNg+ cells in the hippocampus during recovery are CD8+ T cells, and these persist
in the hippocampus for at least a month after viral clearance. IFNγ-Thy1.1 reporter mice were
infected with ZIKV or WNV and cells were isolated from the hippocampus at 25 or 52 dpi for
flow cytometric analysis. (a) Representative gating strategy to identify CD45+IFNg+ cells, which
were further analyzed according to the gating strategy shown in main Figure 3. (b,c) Data from
main Figure 3f,g represented as number of cells (n=4 mice per group, mean + SD). (d,e)
Analysis of CD45+IFNγ+ cells at 52 dpi showed that CD45hiCD11b- CD8+ T cells persist in the
hippocampus at least one month after viral clearance. Data are representative of two independent
experiments (n=3-4 mice per group, mean + SD). Data was analyzed by one-way ANOVA, and
corrected for multiple comparisons. *,P<0.05, **, P<0.005, ***, P<0.001, ****, P<0.0001.
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Figure 3.12 Ifngr1-/- mice display similar clinical course and viral burden as WT mice.
(a-f) Loss of IFNγ signaling does not affect survival, weight loss, or clinical score. (a,d) Survival
analysis (n indicated in the figure). (b,e) No difference in weight loss following infection,
expressed as % of day 0 body weight (b: n=4 WT (mock), 10 WT (WNV), 5 Ifngr1-/- (WNV); e:
n=20 WT (mock), 15 WT (ZIKV), 16 Ifngr1-/- (ZIKV); mean + SD). (c,f) No difference in
clinical score following infection (n as in b,e; mean + SD). (g-i) Loss of IFNγ signaling does not
influence replication or clearance of infectious virus, with the exception of slight delay in the
cerebellum. Viral burden was quantified via standard plaque assays. Data are pooled from two
independent experiments (n=5-15 mice per group; mean + SD). Data was analyzed by log rank
(Mantel-Cox) test (a,d) or two-way ANOVA (b,c,e-i) and corrected for multiple comparisons.
**, P<0.005.
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Figure 3.13 Ifngr1-/- mice have slight decrease in CD103+CD8+ T cells, which express high
levels of CCR2.
(a,b) Loss of IFNγ signaling led to a small but significant decrease in CD103 expression of
CD45hiCD11b-CD8+ T cells isolated from the hippocampus at 25 dpi. Flow cytometric analysis
of cells isolated from the hippocampus of Cx3CR1GFPCCR2RFP or Ifngr1-/-Cx3CR1GFPCCR2RFP
animals as in Fig. 2e-f (gating strategy in Supplementary Fig 2). Data are pooled from two
independent experiments (n=3-8 mice per group; mean + SD). (c,d) Loss of IFNγ signaling did
not influence CCR2 expression, which was high increased in CD45hiCD11b-CD8+ T cells
isolated from the hippocampus at 25 dpi. Flow cytometric analysis of cells isolated from the
hippocampus of Cx3CR1GFPCCR2RFP or Ifngr1-/-Cx3CR1GFPCCR2RFP animals as in Fig. 2e-f
(gating strategy in Supplementary Fig 2). Data are pooled from two independent experiments
(n=3-8 mice per group; mean + SD). Data was analyzed by two-way ANOVA and corrected for
multiple comparisons (a-d). **, P<0.005, ***, P<0.001, ****, P<0.0001.
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Figure 3.14 Decreases in post-synaptic terminals and increase in apoptotic neurons are
observed during ZIKV acute infection and long-term recovery.
(a,c) ZIKV infection does not target glutamatergic termini (Vglut1) or GABAergic (GAD67)
neurons at 25 dpi. Data are pooled from two independent experiments (n=4-8 mice per group,
mean ± SD). (c) No difference in new neurons within the DG during recovery. Representative
images of recovered hippocampus at 52 dpi, assessed after BrdU labeling during acute infection;
BrdU (red), NeuN (green), DAPI (blue). Data from one experiment (n=4 mice, mean ± SD).
Scale bar 50 µm. (d) ZIKV infection leads to decreased number of neurons at 52 dpi. More
neurons were found in Ifngr1-/- recovered mice. Representative images of the recovered
hippocampus, NeuN (green). Data are pooled from two independent experiments (n=4-5 mice
per group, mean ± SD). Scale bar 20 µm. (e) WNV infection leads to the acute loss of
synaptophysin+ pre-synaptic terminals. Data are pooled from 2 independent experiments (n=4
mice per group, mean ± SD). Scale bar 20 µm. (f-g) ZIKV infection leads to acute loss of
homer1+ post-synaptic terminals, but preservation of synaptophysin+ pre-synaptic terminals (f)
Representative immunostaining in the hippocampus at 7 dpi; Synaptophysin (red), DAPI (blue).
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Data are pooled from 2 independent experiments (n=4 mice per group, mean ± SD). Scale bar 10
µm. (g) Representative immunostaining in the hippocampus at 7 dpi; Homer1 (green), DAPI
(blue). Data are pooled from 2 independent experiments (n=4 mice per group, mean ± SD). Scale
bar 10 µm. Data was analyzed by two-way ANOVA and corrected for multiple comparisons (ag). *,P<0.05, **, P<0.005, ***, P<0.001.
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Figure 3.15 Significant differences in numbers of microglia in the hippocampus of WT and
Ifngr1-/- WNV and ZIKV-recovered mice.
(a) Astrocyte expression of IL-1b was similarly elevated in WT and Ifngr1-/- mice.
Representative immunostaining in the hippocampus; GFAP (green), IL-1b (red), DAPI (blue).
Data are pooled from 3 independent experiments (n=4-8 mice per group, mean + SD). Scale bar
50 µm. (b-e) ZIKV- and WNV-recovered animals demonstrate similar numbers of microglia in
the hippocampus at 25 dpi. (b,c) No differences in the number of
CD45midCD11b+Cx3CR1+CCR2- microglia were observed in cells isolated from the ZIKA- or
WNV-recovered hippocampus of reporter mice at 25 dpi. Representative plots of
CD45midCD11b+ cells. Data are representative of two independent experiments (n=3 mice per
group, mean ± SD). (d,e) No differences in the number of Tmem119+ microglia were observed
in the hippocampus of WT and Ifngr1-/- infected animals at 25 dpi. Representative
immunostaining of Tmem119 (green) and DAPI (blue) in the hippocampus. Data are pooled
from two independent experiments (n=4-8 mice per group, mean ± SD). Data was analyzed by
unpaired t test (a-d). (f,g) WNV or ZIKV infection induces increased expression of MHC-II in
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hippocampal microglia at 25 dpi. Representative plots from flow cytometric analysis of MHC-II
expression in CD45midCD11b+Cx3CR1+CCR2- microglia isolated from the recovered
hippocampus of infected WT and Ifngr1-/- animals. Data are pooled from two independent
experiments (n=8 mice per group, mean ± SD). Data was analyzed by two-way ANOVA and
corrected for multiple comparisons (a,f,g). *,P<0.05, ***, P<0.001, ****, P<0.0001.
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Figure 3.16 Conditional deletion of IFNGR in Cx3CR1+ microglia
Specific deletion of IFNGR in microglia was achieved as in Fig. 8a-g. (a,b) Flow cytometric
analysis of CD45midCD11b+ microglia isolated from the hippocampus of Cx3CR1CreERIfngrfl/fl
(Cre +) mice and Cx3CR1Cre-Ifngrfl/fl (Cre-) littermate controls after behavioral testing
demonstrated significant deletion of IFNGR in Cre+ mice. Data are pooled from two
independent experiments (n=4-7 mice per group, mean + SD). (c) Analysis of peripheral myeloid
cells isolated from the blood (PBMCs) and spleen revealed no difference in IFNGR expression
between Cre+ and Cre- mice. Data are representative of two independent experiments (n=4 mice
per group, mean + SD). (d) Tamoxifen treatment did not alter IFNGR expression in
CD45hiCD11b-CD8+ or CD45hiCD11b-CD4+ T cells isolated from the hippocampus of Cre+ and
Cre- mice. Data are representative of two independent experiments (n=4 mice per group, mean +
SD). (e,f) Conditional deletion of IFNGR in microglia during recovery led to significant
attenuation of MHC-II expression in microglia isolated from the hippocampus of Cre+ but not
Cre- mice after behavioral testing. Data are pooled from two independent experiments (n=4-7
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mice per group, mean + SD). Data was analyzed by two-way ANOVA and corrected for multiple
comparisons (a,b,e,f) or by unpaired t test (c,d). *,P<0.05, **, P<0.005, ****, P<0.0001.

125

Figure 3.17 T cell-derived IFNg targets microglia to mediate neurocognitive dysfunction
during recovery from WNV and ZIKV infection.
(a) WNV infects neurons throughout the CNS. Anti-viral T cells that persist in the CNS after
viral recovery produce IFNγ. IFNγ targeting of microglia leads to the elimination of presynaptic
termini, most prominently in the CA3 region of the hippocampus, and the development of spatial
learning and memory deficits. (b) ZIKV preferentially targets neurons in the hippocampus. Like
WNV, IFNγ producing T cells persist in the CNS after ZIKV recovery. Targeting microglia,
IFNγ induced apoptosis of neurons and the elimination of post-synaptic termini throughout the
hippocampus. ZIKV inflicted mice subsequently develop spatial learning and memory deficits.
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Chapter 4: Conclusions and future directions
4.1 Astrocytes, neurogenesis and synapse recovery
This work has explored the fundamental processes which prevent cognitive recovery
following neuroinvasive disease with West Nile virus. We found that in the case of West Nile
Virus, reactive astrocytes prevent recovery of synapses and lead to decreased neurogenesis
through IL-1b signaling. Blocking this pathway through genetic deletion of the receptor for IL-1
(Il1r1-/-) or pharmacologic treatment with the IL1R1 antagonist anakinra was sufficient to
protect animals from WNV-induced spatial learning deficits.
In earlier work we demonstrated that after WNV infection, activated microglia cause
synapse elimination in the hippocampus through complement mediated phagocytosis1, providing
a pathological basis for the spatial learning deficits we observed. Synapses are lost during acute
infection, but what prevents synaptic repair? In the ventral spinal cord, depletion of regionrestricted astrocytes led to differential loss of excitatory and increase of inhibitory synapses.
Astrocytes from developmentally distinct regions did not migrate into the depleted area, and thus
could not replace the cells that were lost2. This raises two important points which may be
relevant for understanding the mechanisms underlying synaptic recovery following viral
infection.
First, in addition to their developmental role of promoting synaptogenesis astrocytes may
also be important for maintaining synaptic connections. In vivo imaging studies have
demonstrated that synaptic connections are formed and lost in a dynamic way even under normal
conditions3. Thus, during recovery from infection reactive astrocytes may lose the ability to
perform homeostatic maintenance of synapse formation and loss. Indeed, recent work has
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demonstrated that reactive astrocytes were unable to promote synapse formation in vitro,
although resting astrocytes readily performed this function4.
Second, astrocytic patterning during development may be an important determinant of the
functional capabilities and the region-restricted areas in which they divide. Indeed, depletion of
astrocytes in a restricted region of the spinal cord led to loss of those astrocytes without
infiltration of astrocytes from an adjacent region2. Thus, as reactive astrocytes lose their
homeostatic functions following WNV infection, it is unlikely that neighboring astrocytes will be
able to migrate into the region to fill the functional void.
However, there are several important caveats to this second line of reasoning. First,
although patterning has been demonstrated for the spinal cord2, no studies have explored whether
hippocampal astrocytes derive from a developmentally restricted region. Second, in vivo imaging
studies have shown that during development, differentiated astrocytes locally proliferate and
integrate into functional networks5, and the daughter cells do not appear to migrate tangentially2.
In the neurogenic zone of the hippocampus, newly generated astrocytes may also contribute to
reactive astrogliosis following infection. Indeed, we observed an increase in proliferating
astrocytes and a decrease in proliferating neuroblasts. Why these newly generated astrocytes are
unable to perform homeostatic functions remains unknown, although it is likely that the
inflammatory environment promotes a reactive phenotype. In vivo imaging of the astrocyte
response to infection could address 1) the dynamics of synapse formation and retraction during
recovery and 2) the contribution of local proliferation and/or migration to reactive astrogliosis.
We also observed decreases in the number of proliferating neuroblasts in the subgranular
zone of the dentate gyrus and the subventricular zone of the lateral ventricles following WNV
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infection6. This loss of neural progenitor cells was not due to direct viral targeting, but rather due
to cytokine mediated alteration in lineage fate. During development, neurogenesis precedes
astrogenesis. The ‘gliogenic switch’, when neural stem cells switch from making new neurons to
making new glia, is mediated in part by JAK-STAT signaling7. It is possible that developmental
pathways leading to gliogenesis are activated when neural stem cells residing in the dentate
gyrus, which typically make new neurons that integrate into the hippocampal circuitry, are
exposed to a cytokine milieu following infection. In addition to the effects of reactive
astrocytosis on synaptogenesis discussed above, the loss of newborn neurons may also contribute
to spatial learning deficits.
Studies in rodents have identified several ways by which adult neurogenesis in the
hippocampus contributes to spatial learning and memory. Adult-born new neurons are integrated
into the hippocampus during spatial learning8, and ablation of neural stem cells or young neurons
prevents learning9,10. Thus, following infection decreases in the proliferating neural precursor
pool, may lead to a decrease in the number of new neurons generated and integrated into the
hippocampal circuitry. Injecting BrdU, which labels dividing cells, at various days post infection
during recovery, in combination with staining for early activation genes could help to identify
whether there is indeed a decrease in the number of newborn neurons incorporating into the
hippocampal circuit during a hippocampal-based memory paradigm.
Although initially dismissed, the hypothesis that neurogenesis exists in the adult human
brain has been widely accepted for many years due to mounting evidence that precursor cells can
be found in restricted neurogenic regions. However, two papers published recently have revived
the debate. Sorrell et. al analyzed human tissue from birth to 77 years and found a sharp decline
in the number of proliferating progenitor cells in the dentate gyrus beginning around 1 year, and
129

very few cells in any of the later time points. They also found a similar decrease in neural
progenitors with age in non-human primates11. On the other hand, Boldrini et al analyzed human
tissue ranging from 14-79 years of age, using stereologic techniques to quantify and extrapolate
the number of newborn neurons in the hippocampus. They identified neural progenitor cells and
found a stable population during aging12. These studies arrived at different conclusions but raise
several important points. First, rodent studies are important and useful for testing mechanistic
hypotheses, but have recognized limits in translating findings to humans due to fundamental
differences in physiology. Second, human studies utilizing post-mortem tissue are an important
step to validate hypotheses generated in rodent studies, but have additional challenges due to an
increasing number of variables, including prior exposures and post-mortem interval, which are
difficult to fully control. Finally, the ability to determine whether neurogenesis continues during
adulthood is limited by the identification and availability of lineage defining markers.
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